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ABSTRACT  
   
Coronaviruses are a medically significant group of viruses that cause 
respiratory and enteric infections in humans and a broad range of animals. 
Coronaviruses assemble at the internal membranes of the endoplasmic reticulum- 
Golgi intermediate compartment (ERGIC). While there is a basic understanding 
of how viruses assemble at these membranes, the full mechanistic details are not 
understood. The coronavirus envelope (E) protein is a small multifunctional 
viroporin protein that plays a role in virus assembly but its function is unknown. 
The two goals of this study were : 1. To identify and analyze the localization of 
MHV E and 2. To identify the functions of conserved residues in the tail of the E 
protein. This study closely examined the localization, dynamics and mobility of 
the mouse hepatitis virus (MHV) E protein to gain insight into its functions. The 
results from the first aim of this study showed that the MHV E protein localizes at 
the site of assembly in the ERGIC-Golgi region based on analysis by 
immunofluorescence and correlative electron microscopy. A novel tetra-cysteine 
tagged MHV E protein was used to study the dynamics of the protein in cells. A 
recombinant MHV E Lumio virus was used to study the trafficking and mobility 
of the E protein. Live cell imaging and surface biotinylation confirmed that the E 
protein does not traffic to the cell surface. Fluorescence recovery after photo-
bleaching (FRAP) analyses revealed that the E protein is mobile at the site of 
localization. As a part of the second aim, conserved prolines and tyrosine in the 
tail of the protein were targeted by site directed mutagenesis and analyzed for 
functionality. While none of the residues were absolutely essential for localization 
  ii 
or virus production, the mutations had varying degrees of effect on envelope 
formation, protein stability and virus release. Differential scanning calorimetry 
data suggests that the proline and tyrosine residues enhance interaction with 
lipids. A wild type (WT) peptide contained the conserved residues was also able 
to significantly reduce the hexagonal phase transition temperature of lipids, 
whereas a mutant peptide with alanine substitutions for the residues did not cause 
a temperature shift. This suggests that the peptide can induce a negative curvature 
in lipids. The E protein may be playing a role as a scaffold to allow membrane 
bending to initiate budding or possibly scission. This data, along with the 
localization data, suggests that the E protein plays a mechanistic role at the site of 
virus assembly possibly by remodeling the membrane thereby allowing virus 
budding and/or scission. 
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INTRODUCTION 
 
Coronaviruses are medically significant viruses that cause a variety of 
respiratory and enteric diseases in humans and a broad range of domesticated 
animals. Roughly 30% of upper respiratory infections that cause common cold 
like symptoms in humans are caused by coronaviruses and they have relatively 
mild symptoms. Before 2002, coronaviruses were mainly studied because of the 
devastating effects they had on the cattle and poultry industry. In 2002, the 
emergence of a new virus - the severe acute respiratory syndrome (SARS) 
demonstrated the lethality of coronavirus infections in humans. The virus caused 
significant economic and social disruption. Two novel human coronaviruses – 
HKU1 and NL63, have been discovered since. The identification of SARS-like 
coronaviruses in various animal reservoirs allows the potential for re-emergence. 
Thus it is essential to understand these viruses to better facilitate the development 
of vaccines and anti virals. The focus of this dissertation, virus assembly, is a 
good target for development of antiviral reagents.  
Coronaviruses are single stranded positive sense RNA viruses with a 
genome size of up to 31kb. These viruses belong the Coronaviridae family in the 
Nidovirales order. The viral envelope contains three main structural proteins. The 
spike (S) protein decorates the viral envelope giving the virus the classic crown 
like appearance (corona in Latin). The membrane (M) protein is the most 
abundant protein in the viral envelope. M interacts with itself and other structural 
proteins to form the virus lattice and organizes assembly. The singe stranded 
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RNA genome is encapsidated by the nucleocapsid (N) protein to form a helical 
nucleocapsid. The envelope (E) protein is a minor component of the viral 
envelope but previous studies indicate that it plays an important role in virus 
assembly.  
The coronavirus E protein is a small viroporin protein ranging from 12- 
15kD. There is very low sequence homology among the coronavirus E proteins, 
but the overall structure of the proteins remains the same. There is a short amino 
terminus, followed by a long hydrophobic domain, and a long highly charged 
carboxy tail. The protein is palmitoylated and membrane associated. The minimal 
requirements for the formation of MHV virus like particles (VLPs) are the 
expression of the E and M proteins.  Coronavirus assembly occurs at the internal 
membranes of the endoplasmic reticulum Golgi intermediate compartment 
(ERGIC) and Golgi. This study closely examined the localization of the MHV E 
protein. The E protein was found to localize at the ERGIC-Golgi membranes. 
This was the first study to determine the dynamics of the E protein using a novel 
tetracysteine tagged system.  Correlative light electron microscopy (CLEM) was 
established and the localization of the E protein was further confirmed to be the in 
the Golgi. The tail of the E protein has two highly conserved prolines and 
tyrosine. We hypothesized that these conserved residues play a critical role in the 
function of the E protein. Results from this study suggest that the tail of the E 
protein may play a role in inducing membrane curvature at the site of assembly. 
We identified that these residues played a critical role in the membrane interaction 
of the E protein and likely affects virus assembly.
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Chapter 1 
LITERATURE REVIEW 
History and classification of Coronaviruses 
Viruses are intracellular parasites that have evolved and co-existed with all 
life forms. The first non-bacterial infectious agent was described in 1892 and the 
first virus - Tobacco Mosaic Virus was described in 1898 (Lustig and Levine 
1992). Since then, more than 5000 viruses have been discovered. Viruses can 
manifest in a wide range of ways, ranging from asymptomatically co-existing in 
their host or replicate aggressively, destroying the host cells in the process. 
Viruses have co- evolved with every life form.  
Coronaviruses were first discovered in the 1930’s (Schalk & Hawn 1931). 
The first identified coronavirus was from poultry, called avian infectious 
bronchitis virus (IBV) followed by murine hepatitis virues (MHV) and 
transmissible gastroenteritis virus (TGEV) found in pigs (Beaudette 1950; Bailey 
et al. 1949; Doyle and Hutchings 1946). The first human coronavirus was 
identified in the 1968 from fecal matter (Tyrrell, Bynoe, and Hoorn 1968).  The 
coronavirus genus was defined based on the crown-like appearance produced by 
the surface glycoprotein, and thus resulting in the name corona which is Latin for 
crown (Lecce, King, and Mock 1976). 
 Coronaviruses are in the order Nidovirales along with Arteriviridae and 
Roniviridae. All viruses in this order have an RNA genome and carry out RNA 
synthesis using a discontinuous negative stranded synthesis mechanism for 
transcription (S. G. Sawicki and Sawicki 1990). They all produce a 3’-co-terminal 
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nested set of subgenomic mRNAs.  Coronaviruses are in the Coronaviridae 
family along with the Torovirus genus. While they have similar genome 
organization and replicate using similar strategies, the torovirus genome is 
smaller, at about 28 kb (Cavanagh et al. 1993). The viral replicase gene encodes 
the key functions required for coronavirus RNA synthesis. The gene comprises 
more than 20,000 nucleotides and encodes two replicase polyproteins, pp1a and 
pp1ab, that are proteolytically processed by viral proteases (Flint, Enquist, and 
Racaniello 2009). The replicase genes are encoded by two-thirds of the genome. 
All the viral structural proteins are translated from the subgenomic mRNAs 
(Lecce, King, and Mock 1976; Cavanagh 1997; Cavanagh et al. 1990). 
Evolution of Coronaviruses 
Coronaviruses are separated into four groups based on various serological 
assays including antibody cross reactivity, neutralization from sera of infected 
hosts (Siddell 1995; Dea, Verbeek, and Tijssen 1990; Flint, Enquist, and 
Racaniello 2009) (Fig. 1) Each group is further characterized according to their 
host and diseases which they cause (F. Li 2012). Coronaviruses infect a wide 
range of animals and humans. Since the identification of the first coronavirus in 
the 1930’s, several new coronaviruses have been identified in both animals and 
humans. Coronaviruses mainly cause respiratory and enteric infections in humans 
and domesticated animals (Table 1). Evolution of different strains of 
coronaviruses among various hosts have also been studied using sequence 
analysis of different viral genes (Siddell 1995). 
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 Until recently, a large emphasis on understanding coronavirus infection 
was to develop vaccines against viruses that infected pets and cattle. Severe 
infections in humans were not identified even though up to 30% of all common 
colds have been attributed to coronaviruses (Hamre and Procknow 1966; 
McIntosh et al. 1967; Tyrrell, Bynoe, and Hoorn 1968; El-Sahly et al. 2000).  
However, a novel coronavirus emerged in 2003 and was named severe acute 
respiratory syndrome coronavirus (SARS-CoV). The emergence of SARS of 
epidemic not only had significant impact on global economics and trade but 
caused up to 40% mortality in children and elderly people (Kienzle et al. 1990; 
Ksiazek et al. 2003).  The World Health Organization (WHO) estimated that 8000 
cases were confirmed with 10% mortality rate (Parry 2003).  SARS-CoV causes 
more severe disease then other previously known human coronaviruses and 
results in atypical pneumonia, fever, and shortness of breath (Lewicki and 
Gallagher 2002; Ksiazek et al. 2003).  It was originally thought SARS-CoV 
originated exotic trade in China but it has now been identified from sequencing 
data that the reservoir is likely bats (Gagneten et al. 1995; Lau et al. 2005; W. Li 
et al. 2005).  Although the epidemic died out naturally and controlled by careful 
health practices, the identification of SARS-like coronaviruses in bat reservoirs 
keeps the possibility of re-emergence of SARS-CoV or SARS like viruses alive 
(Thorp et al. 2006; Tong et al. 2009).  Since the emergence of SARS, two new 
human coronaviruses have been isolated- HKU-1 and NL-63. Both HKU-1 and 
NL-63 coronaviruses infect infants but only cause mild respiratory diseases 
compared to SARS-CoV infection (Lau et.al 2006; Sloots et.al 2006). 
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Group Virus Host Respiratory Enteric Hepatitis Neurologic Other* 
Alpha 
  
  
  
  
  
HCoV-229E Human X 
    HCoV-NL63 Human X 
    TGEV Pig X X X 
  CCoV Dog 
 
X 
   FIPV Cat X X X X X 
RbCoV Rabbit 
  
X 
        
     
Beta 
  
  
  
  
HCoV-OC43 Human  X 
    SARS-CoV Humans X X 
   HCoV-HKU1 Humans X X 
   MHCoV Mouse X X 
 
X 
 HECoV Pig X X 
         
     
Gamma 
  
IBV Chicken X 
 
X 
 
X 
TCV Turkey X X 
             
   
Delta #   
Wild aquatic 
birds 
 
    
                  
* Infectious peritonitis, immunological disorders, nephritis, pancreatitis, etc 
# Suggested new group 
Table 1: Coronavirus classification, hosts and infections 
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Figure 1: Evolution of Coronaviruses: 
  Currently, coronaviruses are classified into four groups. Classification into 
each group depends on immunogenicity of the spike proteins on the virus. Viruses 
can recombine with each other when co-infected in a host to give rise to new 
strains. 
Woo P C Y et al. J. Virol. 2012; 86: 3995-4008 
Reproduced with permission from Journal of Virology  
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Coronaviruses infections in cattle and domesticated animals have a 
significant impact on the global poultry, cattle and swine industries. TGEV 
infections are highly transmissible and can cause large-scale fatal diarrhea in pigs 
(Lecce, King, and Mock 1976).  IBV infections cause wide spread death in 
poultry farms. Canine coronavirus infections are vaccine preventable (Pratelli et 
al. 2003) whereas feline coronavirus infections are fatal. 
Virion morphology and structure 
 Coronaviruses are enveloped viruses with a single stranded positive sense 
RNA genome.  They have the largest known RNA genome ranging from 27- 
31kb. The viruses are pleomorphic and range from 100- 120 nm in size (Flint, 
Enquist, and Racaniello 2009; Lai and Cavanagh 1997).  The large genome is 
bound by the nucleocapsid (N) protein to form a helical nucleocapsid (Flint, 
Enquist, and Racaniello 2009). The viral envelope is derived from host 
membranes. Three main structural proteins, the spike (S), membrane (M), and 
envelope (E) proteins are anchored in the envelope (Fig. 2). Some coronaviruses 
also contain the hemagglutinin esterase (HA) protein in the viral envelope 
(Kienzle et al. 1990) .  
Structural Proteins 
Spike (S) Protein 
The spike (S) protein is present in the virion envelope, and protrudes to 
give the characteristic crown like appearance to the virus (Fig. 2). The S protein 
initiates infection by binding to cellular receptors. Neutralizing antibodies are 
  7 
produced against the S protein during infection(Jiménez et al. 1986) . The S 
protein is a large glycoprotein that is roughly 150-180kD in size and is thought to 
form trimers in the viral envelope (Cavanagh 1983; Luytjes et al. 1988; Lewicki 
and Gallagher 2002; Delmas and Laude 1990). The S protein is a type I 
membrane protein that has a short C terminal endo-domain, followed by a 
transmembrane domain and a large N terminal domain that extends outside the 
virion. The protein is highly glycosylated and during maturation of the S protein 
in the cell, it is cleaved by cellular proteases to form S1 and S2 regions that 
remain non-covalently associated (Sturman et.al. 1990). The globular S1 region 
binds to host cell receptor and there is a lot of variability in the S1 sequence 
among coronaviruses giving a wide range of hosts for coronaviruses to infect. The 
S2 region constitutes the stalk region of S and is not exposed to the immune 
system. There are two conserved heptad repeats in the S2 region and they are 
thought to form a coiled-coil structure (Siddell 1995; Gagneten et al. 1995). Once 
the S1 binds to the cellular receptor, the S2 region is important for mediating 
fusion between viral and host membranes (Fleming et al. 1983; Thorp et al. 2006; 
Ziebuhr 2005; Z. Luo and Weiss 1998). For SARS, cleavage of S1 and S2 occurs 
during entry by an unknown mechanism (Cavanagh 1997; Sturman and Holmes 
1977; Hsieh et al. 2005). However, the S proteins of group I coronaviruses are not 
cleaved (De Haan et al. 2008; de Groot et al. 1989).  
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Figure 2: Coronavirus virion schematic 
The virus envelope is depicted in gray. The viral envelope proteins spike 
(S), membrane (M) and envelope (E) are shown in green, purple and cyan 
respectively. The RNA genome (red) is encapsidated by the nucleocapsid (N) 
protein shown in blue. 
!"#$%!&'&()$%
*+%,% !"#$%
S 
RNA 
M 
N 
E 
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The S protein initiates the coronavirus infection. S is highly immunogenic 
and is recognized by many monoclonal neutralizing antibodies (Shih et al. 2006). 
The S2 region mediates extensive fusion between viral and cell membranes and 
cell to cell membranes (Gombold, Hingley, and Weiss 1993; Routledge et al. 
1991). This causes a cytopathic effect which is characteristic of betacoronavirus 
infection (Gombold, Hingley, and Weiss 1993). The S protein traffics to the cell 
surface in the absence of the M protein and mediates cell-to-cell fusion. Crystal 
structures N terminal domain of S, along with the MHV receptor have been 
obtained (Peng et al. 2011).  
Hemagglutinin-esterase (HE) protein 
The HE glycoprotein is found on the virion of some beta and gamma 
coronaviruses (Siddell 1995).  Coronaviruses lacking the HE protein do not have 
a significant effect in virulence in vivo and the HE gene is frequently lost in 
viruses passaged in cell culture. It has been proposed that a co-infection of a host 
with a coronavirus and Influenza C virus allowed a recombination to incorporate 
HE into the coronavirus genome (Luytjes et al. 1988).  It is a 65 kD glycoprotein 
that forms short spikes in the viral envelope. It associates with the S and M 
proteins in infected cells. It exists as disulfide linked dimers and has both 
heagglutinating and esterase activity (Siddell 1995; Hogue, Kienzle, and Brian 
1989).  It is unknown whether the protein plays a role in virus entry or release or 
both. However, by itself, it cannot initiate infection and S protein is required for 
this process (Fleming et al. 1983; Ziebuhr 2005). The HE protein is not essential 
for virus replication and assembly in cell culture. Upon repeated passaging, the 
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HE protein is deleted or mutated in the genome (Cavanagh 1997). In some strains 
of MHV, the HE protein increases neurovirulence in mice (Kazi et al. 2005).  
Membrane (M) Protein 
 The M protein is the most abundant protein in the viral envelope (Fig. 2). 
It is a type III membrane protein and is about 25 kD in size (Locker et al. 1992).  
It has a short amino terminus followed by three membrane-spanning domains and 
a long carboxy tail located inside the virion (Locker et al. 1992). For 
alphacronaviruses like TGEV both amino and carboxy ends of the M protein are 
possibly located on the outside of the virion (Risco et al. 1995). M localizes in the 
Golgi region when expressed alone (Klumperman et al. 1994; Krijnse-Locker et 
al. 1994). The amino terminus is O- or N-linked glycosylated depending on the 
virus classification (Voss et al. 2009; Niemann et al. 1984; S. A. Tooze, Tooze, 
and Warren 1988; Niemann et al. 1984; Lai and Cavanagh 1997; Oostra et al. 
2006). While glycosylation does not appear to be important for correct 
localization of the protein or virus production, it has been implicated to play a role 
in interferon induction (de Haan et al. 2003; de Haan et al. 1998). The M protein 
and its interactions with viral and host proteins drives virus assembly (Wang et al. 
2009). M molecules interact with each other to form a lattice and M also interacts 
with the S protein and nucleocapsid during virus assembly (de Haan et al. 1999; 
de Haan, Vennema, and Rottier 2000; Escors et al. 2001; Kuo and Masters 2002; 
Nguyen and Hogue 1997; Opstelten et al. 1995). The S protein and a small 
number of E molecules are interspersed in the M protein lattice in mature virions. 
The M-N interaction involves the carboxy end of both M and N proteins and it 
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occurs in the absence of the S and E proteins (Hurst et al. 2005; Kuo and Masters 
2002; H. Luo et al. 2006; Narayanan et al. 2000; Verma et al. 2006). The M 
protein also interacts directly with the RNA packaging signal further increasing 
the specificity of packaging only of nucleocapsids associated with full length 
genomic RNA (Narayanan and Makino 2001). Coronavirus M proteins also 
interact with host proteins. For example, specific domain in the IBV M have been 
shown to interact with beta-actin (Wang et al. 2009) and results suggest this 
interaction may be important for virus assembly and budding.  
Nucleocapsid (N) protein    
 The N protein is a highly basic nucleic acid binding protein rich in lysines 
and arginines. It is approximately 55kD and is phosphorylated (Wilbur et al. 
1986; Molenkamp and Spaan 1997; White, Yi, and Hogue 2007). The protein can 
be divided into three domains (Parker and Masters 1990). The amino and central 
domains have an overall positive charge and the carboxy domain has an overall 
negative charge (Parker and Masters 1990). The sequences in between the 
domains are highly variable. Specific phosphorylation sites have been identified 
for TGEV, MHV, SARS-CoV and IBV and the sites are clustered around the 
amino- central domains and at the carboxy domain (Calvo et al. 2005; H. Chen et 
al. 2005; White, Yi, and Hogue 2007). The primary function of the N protein is 
encapsidation of the genomic RNA (Fig.2). This forms a flexible helical 
nucleocapsid (Narayanan, Kim, and Makino 2003; Baric et al. 1988; Chang and 
Brian 1996; Macneughton and Davies 1978). The domains required for RNA 
binding are different in different viruses. In IBV and SARS N, the RNA binding 
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region is the amino terminal (Zhou and Collisson 2000). For MHV, the RNA 
binding domain is the central domain (Q. Huang et al. 2004).  The sequence 
specificity of RNA binding to N is unknown, but the N protein does specifically 
binds to the packaging signal (Cologna, Spagnolo, and Hogue 2000). The 
conserved SR- rich region has been identified for N multimerization and cellular 
localization (H. Luo et al. 2005). The N protein may also play a role in inhibiting 
host cell translation (Tsui-Yi Peng, Lee, and Tarn 2008). The N protein can non 
specifically bind to the genomic RNA, as well as the 5’ leader, 3’ untranslated 
region (UTR) and the packaging signal (Cologna and Hogue 2000; Masters 1992; 
Molenkamp and Spaan 1997; Nelson and Stohlman 1993; Nelson, Stohlman, and 
Tahara 2000).  The N protein may also function as an RNA chaperone, playing a 
role in RNA synthesis, stability and increase the efficiency of replication 
(Almazán, Galán, and Enjuanes 2004; Chang and Brian 1996; Schelle et al. 2005; 
Yount, Curtis, and Baric 2000; Yount et al. 2002). It may play a role in template 
switching during transcription.  The N protein also plays a role in virus assembly 
and is an important structural protein. The interaction of the N protein with the M 
protein likely results in the envelopment of the nucleocapsid into the viral 
particle. Specific residues in the carboxy domain of the M and N proteins are 
required for M-N interactions (Verma et al. 2006; Verma et al. 2007).  The N 
protein may also function as an interferon antagonist (Ye et al. 2007).  
Envelope (E) Protein 
 The E protein is present in low abundance in the virion envelope It is 9-12 
kD in size is the focus of this dissertation. All coronavirus E proteins share similar 
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conserved characteristics. These include a short amino terminus, a long 
hydrophobic transmembrane region, and a cysteine-rich region after the 
hydrophobic domain, conserved prolines, and a highly charged carboxy terminal 
domain. Two topologies have been reported for E proteins where it spans the 
membrane once or twice depending on the virus strain (Maeda et al. 2001; Arbely 
et al. 2004). The SARS E protein has been shown to localize at the membranes of 
ERGIC/Golgi (Cohen, Lin, and Machamer 2011).  The MHV E protein is 
predicted to have two membrane topologies, with the carboxy tail always in the 
cytoplasm. (Fig. 3) (Maeda et al. 2001). The hydrophobic domain of the E protein 
is predicted to form an amphipathic helix and affecting the pitch of the helix 
impacts the ion channel activity of the protein and virus production and release 
(Ye and Hogue 2007). The transmembrane domain of IBV E protein can be 
replaced with the transmembrane domain from VSV-G, with effects on VLP 
formation and protein localization (Ruch and Machamer 2011). The 
transmembrane domain of IBV E may affect trafficking of host protein in the cells 
(Ruch and Machamer 2011). Additionally, E is palmitoylated on cysteine residues 
in the cysteine-rich region for several coronaviruses. The palmitoylation of the 
cysteine residues are important for protein stability and virion trafficking 
(Boscarino et al. 2008; Lopez et al. 2008). It has been proposed that the insertion 
of the palmitic acid modifications can anchor the protein in the membrane by 
insertion into the membrane (Lopez et al. 2008) 
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Figure 3: The Envelope protein 
The envelope protein has a small amino end followed by a long transmembrane 
domain that spans the lipid bilayer once. The conserved cysteines are 
palmitoylated. The tail is highly charged and is oriented towards the cytoplasm or 
inside the virion. The cysteines are at residues 40, 44 and 47. The conserved 
prolines are at residues 54 and 76. 
Adapted from Lopez et.al., J Virol. 2008 Mar;82(6):3000-10. 
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When charged residues within the carboxy domain of E were mutated to 
neutrally charged alanines, virions displayed an aberrant morphology and low 
thermo-stability (Fischer et al. 1998). A putative localization signal has been 
identified in the tail of the E protein that is predicted to form a helix-turn helix 
.(Cohen, Lin, and Machamer 2011). The MHV M and E proteins are sufficient 
and required for budding of virus-like particles (VLPs) (de Haan, Vennema, and 
Rottier 2000). However, when expressed alone the E protein is released from 
transfected and infected cells in the form of vesicles (J. Maeda, Maeda, and 
Makino 1999). Therefore, it is thought that the E protein triggers virus assembly. 
The E protein also causes local membrane modifications in the cell called tubular 
bodies (Ulasli et al. 2010; Raamsman et al. 2000). The exact role of E has not 
been elucidated but it has been shown to play an important role in virus 
production. Deletion of the E protein from the viral genome results in a varying 
phenotype that is strain dependent. Absence of TGEV E results in a lethal 
phenotype whereas deletion of E from SARS-CoV causes only a marginal 
decrease in virus production that is cell type dependent (Ortego et al. 2007; 
DeDiego et al. 2007). Even though MHV E can be deleted from the genome and 
viruses are viable, these mutants grow to titers several logs lower compared to 
WT. Additionally, coronavirus E proteins have been shown to have ion channel 
activity which presumably plays a role in viral entry and/or budding (Wilson, 
Gage, and Ewart 2006; Wilson et al. 2004; Ye and Hogue 2007). NMR data of the 
transmembrane region has helped identify critical pore lining residues in the E 
protein (Pervushin et al. 2009). SARS E protein has been shown to be 
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ubiquitinated, interacts with nsp3 and members of the cellular cytoskeleton 
(Alvarez et al. 2010). This may be playing a role in directing virus trafficking in 
cells. SARS E has also been shown to interact with PALS 1 at tight junctions in 
cells (Teoh et al. 2010). SARS-CoV deleted of the E protein has been shown to be 
effective as a SARS vaccine. This mutant virus causes a much milder infection 
but induces a robust immune response including cytokine response suggesting 
that the E protein may function as a virulence factor (Dediego et al. 2007; 
Dediego et al. 2007; Dediego 2008). 
Coronavirus Genome and Nonstructural Proteins 
Viral Genome 
Coronavirus genome consists of a single stranded, positive sense RNA. 
The genome is a 5’ 7-methyl guanosine capped and a 3’ poly (A) tailed, 
resembling a large cellular mRNA (Schochetman, Stevens, and Simpson 1977). 
Purified genome is infectious (Lai and Cavanagh 1997). There is a leader 
sequence at the 5’ end of the genome and is 65-98 nucleotides in length. This 
leader is also located at the 5’ ends of all the subgenomic mRNAs. There are 
untranslated regions (UTRs) that are about 300 nucleotides at both the 5’ and 3’ 
ends of the genome, which play important roles in RNA replication and 
transcription (Lai and Cavanagh 1997; Spagnolo and Hogue 2000) . Translation 
begins immediately upon virus entry, since the genome is infectious. The first two 
thirds of the genome contain open reading frame (ORF) 1, which encodes ORF1a 
and ORF1b. ORF 1a and ORF1b encode all the proteins necessary for 
transcription and replication.  Translation of ORF 1b occurs after ribosomal 
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frame-shifting at a region between the two ORFs (Brierley et al. 1987; Lai and 
Cavanagh 1997).The last one third of the genome encodes all the structural genes. 
The order of translation is always 5’ S-E-M-N-3’(de Haan et al. 2002). Several 
group specific nonstructural genes are present interspersed among the structural 
ORFs.  The function of the nonstructural proteins is peripheral and is not required 
for replication in cell culture. Deletion of these accessory genes has an impact on 
viral replication in animals, such as MHV replication in mice (de Haan et al. 
2002). Analysis of the SARS-CoV genome revealed the presence of the largest 
number of nonstructural genes identified so far and none of them were essential 
for growth in cell culture (Yount et al. 2005). It is possible that these accessory 
genes contributed to the increased virulence of SARS-CoV. 
Nonstructural Proteins (nsps) 
 
The largest non-structural protein is translated from the first two- thirds of 
the genome. The ORF1a/ b proteins are translated as a large polyprotein which are 
then proteolytically cleaved into the proteins necessary for transcription and 
replication. ORF1 encodes for up to sixteen nonstructural proteins (Ziebuhr 2005; 
Ziebuhr, Snijder, and Gorbalenya 2000). All coronaviruses encode for papainlike 
and chymotrypsinlike proteases from ORF1a (Lai and Cavanagh 1997) . These 
proteases then completely process the ORF1 polyprotein through various 
processing intermediates  (Xu et al. 2001; Ziebuhr and Siddell 1999; Stobart et al. 
2012). These proteases are critical for coronavirus replication and many drugs 
have been developed against SARS-CoV proteases (Ramajayam, Tan, and Liang 
2011).  Since ORF1a encodes for many proteins, most have not been 
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characterized. One of the most well studied non-structural proteins is nsp3. It has 
an ADP-ribose 1’-phosphatase activity and a cylindrical structure. It may have a 
single stranded RNA binding domain and may be important for virus replication 
(Egloff et al. 2004; Saikatendu et al. 2005). ORF1b encodes for the viral RNA 
dependent RNA polymerase (RdRp) (nsp12) and a helicase (nsp13). The nsp13 
also has other enzymatic activities including NTPase, dNTPase, and 5’-
triphosphatase activities.(Seybert et al. 2000) ORF1b also encodes a 3’-to-5’ 
exonuclease (ExoN), a uridylate-specific endoribonuclease (N endoU). In 
addition, the nsp10/nsp16 complex function as an mRNA capping enzyme 2’-O-
methyltransferase (Snijder et al. 2003). The ORF1 proteins localize to regions of 
intracellular membranes. Extensive membrane modification occurs during 
replication (Ulasli et al. 2010).  Some of the nonstructural proteins such as nsp6 
have been implicated in the process, which produce autophagosome utilizing 
membranes of the ER (Cottam et al.2011). Proteins of the replicase complex 
localize to double membrane vesicles (DMVs) around the perinuclear region in 
MHV and SARS CoV (Snijder et al. 2006; Gosert et al. 2002). ORF 8a of SARS 
CoV encodes for an ion channel protein (Chen et al.2011).  
Viral Life Cycle  
Attachment and Entry 
    Coronavirus infection is initiated with the virion attaching to susceptible 
host cell receptors (Fig. 4). This interaction is very specific. The S protein is the 
virus attachment protein that binds to specific receptors found on the cell surface. 
Different coronaviruses use different receptors to initiate infection. Several such 
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receptors of coronavirus infection have been identified. The S- receptor 
determines host specificity and cellular tropism.  The receptor for MHV infection 
is a biliary glycoprotein in the carcinoembryonic antigen family, Ig superfamily 
(CEACAM1) (Dveksler et al. 1991; Williams, Jiang, and Holmes 1991).  The 
MHV S protein binds to the extracellular Ig-like loops of the CEACAM1a 
receptor. CEACAM1 molecules are expressed in the liver and gastrointestinal 
tract, on macrophages, dendritic cells, B cells, and activated T cells in mice (Lai 
and Cavanagh 1997; Nakajima et al. 2002; Turner et al. 2004). 
Alphacoronaviruses utilize a host specific cell membrane-bound metalloprotease 
called aminopeptidase N (APN) as their receptor (Lai and Cavanagh 1997; 
Benbacer et al. 1997). APN is distributed in respiratory and intestinal epithelium 
and on neuronal cells as well as at synaptic junctions (Shapiro et al. 1991). 
Betacoronaviruses use the N-acetyl-9-O-acetylated sialic acid as their receptor on 
host cells (Schultze and Herrler 1992; Künkel and Herrler 1993). The host cell 
receptor for SARS-CoV and HCoV-NL63 is the angiotensin-converting enzyme 2 
(ACE2) (Hofmann et al. 2005; W. Li et al. 2003). ACE2 is expressed in several 
tissues including the heart, lung, kidney and small intestine (Hamming et al. 
2004). 
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Figure 4: Coronavirus lifecycle 
Coronavirus entry is initiated by receptor- mediated endocytosis. Virus 
replication occurs in the cytoplasm, assembly takes place at the membranes of the 
ERGIC and Golgi. Assembled virions traffic out to the cell surface as cargo in 
large vesicles. 
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  Once the S protein binds to the host cell receptor, it undergoes a 
conformational change that allows fusion of viral and host membranes (Zelus et 
al. 2003) (Fig. 4). MHV, BCoV, and IBV induce fusion optimally at a neutral or 
slightly alkaline pH, which suggests these viruses fuse directly with the plasma 
membrane ((Zelus et al. 2003; Payne and Storz 1988; Lai and Cavanagh 1997). 
Some MHV strains appear to enter cells by utilizing the pH dependent endosomal 
pathway (Gallagher and Buchmeier 2001).  For some strains of MHV, infectivity 
is reduced in the presence of acidifying drugs suggesting that they enter the cells 
by utilizing the pH dependent endosomal pathway (Gallagher, Escarmis, and 
Buchmeier 1991). Upon entry, the nucleocapsid protein- RNA complex is 
released into the cytoplasm. In order for the translation machinery to access the 
genome, the RNA is then stripped off the N protein.  The process of release and 
uncoating of the genomic RNA is likely regulated by the phosphorylation of the N 
protein (Spencer et al. 2008). The N protein is a highly basic protein that can be 
phosphorylated, imparting it an overall negative charge. It is possible that 
phosphorylation by virus and host kinases that may lead to the disassociation of N 
from RNA (Mohandas and Dales 1991). Cholesterol is essential for virus entry 
and reduction of cholesterol from the plasma membrane severely inhibits virus 
entry (Choi, Aizaki and Lai 2005). Cellular factors may also be involved in 
coronavirus entry (Asanaka and Lai 1993).   
Transcription and replication 
Upon entry, the RNA-nucleocapsid is released into the cytoplasm. The 
RNA is then uncoated, making it accessible to the cellular translation machinery. 
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Once the translation of the ORF 1a and ORF 1b takes place. The polyprotein is 
then proteolytically processed to generate all proteins required for virus 
transcription and replication (Flint, Enquist, and Racaniello 2009).  In order to 
make mRNAs for the structural genes, the replicase-transcriptase complex 
generates sub-genomic negative-strand RNA molecules (Fig. 5). These are used 
for transcription of subgenomic mRNAs. A 3’ co-terminal nested set of 
subgenomic mRNAs are produced during viral infection. Each subgenomic 
mRNA contains the leader sequence at the 5’ end, identical to the leader as is 
present on the 5’ end of the genome (Lai and Cavanagh 1997). Therefore, they all 
contain the same 5’ and 3’ ends but are of varying lengths. Although, each 
subgenomic mRNA contains more than one ORF, only the most 5’ ORF gets 
translated. Intergenic or transcription-regulatory sequences (TRSs) are present on 
the genomic RNA in between each structural ORF. These TRSs play a role in 
regulation of subgenomic mRNA transcription. There is a sequence similarity 
between the TRS and the 3’ end of the leader sequence. This may play a role in 
template switching to create the 3’ co- terminal nested subgenomic RNAs.   A 
model of discontinuous transcription mechanism was proposed since each 
subgenomic mRNA contains the leader sequence as well as TRSs (Lai et al. 1984; 
Baric, Stohlman, and Lai 1983; Spaan et al. 1983).  Coronavirus replication is 
thought to adapt a discontinuous transcription mechanism during negative-strand 
synthesis. This model proposes that subgenomic mRNA transcription occurs 
during negative-strand RNA synthesis (S. G. Sawicki and Sawicki 1990). The 
polymerase would stall at the TRS sequences and then switch to the 3’ end of the 
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leader that contains homologous sequence to the TRS, to continue transcription. 
This is called template switching (S. G. Sawicki and Sawicki 2005). This results 
in negative-strand subgenomic mRNAs these would serve as template for the 
synthesis positive-strand mRNAs. Full-length positive-and negative-strand 
genomic RNAs are also made during infection. The RNA secondary structures of 
the 5’ and 3’ UTRs as well as may play a role in the modulation between 
replication and transcription (Thorp and Gallagher 2004; Hsue and Masters 1997; 
Goebel et al. 2004). 
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Figure 5: Coronavirus genome and replication 
The coronavirus genome is a single stranded – positive sense RNA. The 
full length genome is replicated into a full length negative strand. This serves as 
template for the production of more full length positive sense genome. A 3’ co-
nested set of discontinuous negative stranded subgenomic RNA is generated. This 
serves as template for monocistronic mRNAs that encode the structural proteins. 
 
 
 
  26 
 Translation 
The full-length coronavirus genome is 5’ capped and 3’ poly A tailed and 
resembles a large mRNA (Schochetman, Stevens, and Simpson 1977).  
 The cellular translation machinery immediately recognizes it and ORF1 is 
translated immediately after infection as one large polyprotein about 800 kD in 
size. ORF1 contains ORF1a and 1b that are in different reading frames. 
Translation of ORF1b occurs after a ribosomal frameshifting takes place during 
the translation of ORF 1a (Brierley et al. 1987). The ORF1 gene encodes all the 
proteins in the transcriptase-replicase complex. The structural proteins are 
translated off the subgenomic mRNAs. Translation is initiated by a traditional 
cap-dependent mechanism because all the subgenomic RNAs are 5’ capped and 
3’ poly-A tailed. Even though the subgenomics contain more than one ORF, 
typically only the most 5’ ORF is translated Cavanagh 1991). The only exception 
is the MHV E protein, which is encoded on subgenomic mRNA 5, is translated 
from the second ORF (Thiel and Siddell 1994). Translation of the E protein 
occurs through a cap-independent internal ribosomal entry site (IRES) (Jendrach, 
Thiel, and Siddell 1999) . 
Assembly and Release 
Most enveloped viruses assemble at the plasma membrane. Coronaviruses, 
flaviviruses and bunyaviruses derive their envelope from the internal membranes. 
Very little information is known about the factors driving virus budding at 
internal membranes. Virus assembly takes place at the ER/Golgi intermediate 
compartment (ERGIC) and Golgi membranes (Fig. 4). At lower temperatures like 
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30 0 C, virus assembly has been observed at the ER (Holmes, personal 
communication).  The viral structural proteins are localized to the site of 
assembly. The S protein is co-translationally inserted into the rough ER (RER). It 
is highly glycosylated and a portion of the protein is transported to the plasma 
membrane through the secretory pathway (Klumperman et al. 1994).  During 
infection or co- expression with M, a large portion of the S protein is retained at 
the site of assembly (McBride and Machamer 2010). The M protein is also co-
translationally inserted into the ER membrane and localizes primarily in the 
ERGIC/ Golgi in infected cell (Klumperman et al. 1994). At the site of assembly, 
the M protein organizes the other structural proteins and drives assembly. The E 
protein localizes at the site of the assembly in the ERGIC/ Golgi region (Cohen, 
Lin, and Machamer 2011). The N protein is soluble and is found in two 
components in the cells- free floating and membrane associated (Verheije et al. 
2010). Replication takes place on double membrane vesicles (DMVs) that are 
generated early in infection. Various non-structural proteins localize to these 
membranes early in infection. N also localizes to the DMVs. It is unknown which 
component of N is associated with the RNA that is then encapsidated into the 
virion. 
The virus assembly process generates various membranous structures in 
the cells that have recently been systematically analyzed (Ulasli et al. 2010). This 
system used peptides to prevent S mediated fusion inside the cells. So all the 
structures observed were due to the replication and assembly processes. The first 
structures to the identified are the DMVs. Following this, convoluted membrane 
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(CM) structures appear, that connect the membranes of the ER with the DMVs. 
The function of this connection is unknown.  Nucleocapsid and replicase proteins 
localize to these structures. The viral structural proteins interact with each other to 
form assembly complexes that help facilitate the assembly and budding process. 
Once replication occurs, virions appear. Virions bud into structures described as 
large virion containing vacuoles (LVCV). Virus structural proteins and ERGIC/ 
Golgi proteins localize to this structure (Fig. 4) Virions traffic out to the cell 
surface in these vesicles. At later times post infection, rare membrane 
modifications occur in the cells. These include tubular bodies (TB) and cubic 
membrane structures (CMS). The functions of these modifications are 
unknown(Ulasli et al. 2010).  
The E protein plays a major role in virus budding and trafficking. 
Although all these protein interactions must take place for efficient assembly of 
infectious particles, the M and E proteins are the minimal requirements for 
envelope formation for MHV, IBV, and BCoV, as they form virus-like particles 
(VLPs) (Vennema et al. 1996).Therefore, it is thought these two viral proteins are 
crucial for assembly of virions. Most enveloped viruses require the nucleocapsid 
for assembly so coronaviruses are unique as they utilize nucleocapsid independent 
assembly. Since the M protein alone cannot drive the assembly process, it is 
thought the E protein plays an important role in assembly and release. Studies 
have suggested that E may induce membrane curvature or could be involved in 
the pinching off of budding virions.  Additionally, when E is expressed alone, 
vesicles are produced and released from cells(Raamsman et al. 2000). While E 
  29 
proteins can substitute for one another in virus assembly with minor changes, the 
exact role of the E protein in each virus strain may different (Kuo, Hurst, and 
Masters 2007). Immediately upon infection, organelle identity is lost. One of the 
hallmarks of MHV infection is the disassembly of the Golgi architecture (Oshiro, 
Schieble, and Lennette 1971). This has been attributed to the E protein and its ion 
channel activity (Ruch and Machamer 2011). The implication of such a 
disassembly for virus assembly is unknown.  
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Chapter 2 
CORONAVIRUS ENVELOPE PROTEIN REMAINS AT THE SITE OF 
ASSEMBLY. 
ABSTRACT 
Coronavirus (CoV) assembly at endoplasmic reticulum Golgi intermediate 
compartment (ERGIC) membranes and egress is not completely elucidated, but 
the envelope (E) protein clearly influences the process.  Mouse hepatitis CoV A59 
E protein localization and dynamics were investigated to further understanding of 
its functions.  E protein localizes in the ERGIC and Golgi with the amino and 
carboxy ends in the lumen and cytoplasm, respectively.  The protein does not 
traffic to the cell surface.  The transmembrane (TMD) domain is not required for 
targeting to intracellular membranes.  A genetically engineered MHV with a 
tetracysteine (TC) tag appended to the carboxy end of E was used for real-time 
imaging during infection.  Fluorescence recovery after photobleaching (FRAP) 
showed that E is not highly mobile in the ERGIC/Golgi region and correlative 
light electron microscopy (CLEM) confirmed its presence in Golgi cisternae.  
Altogether, these results provide strong support for a primary role of E at the site 
of budding/assembly.   
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INTRODUCTION 
 Coronaviruses are medically important enveloped, positive stranded RNA 
viruses that infect humans and a broad range of animals.  At least three proteins 
are present in the lipid envelope, the membrane (M), spike (S) and envelope (E) 
proteins.  The envelope surrounds the ~30 kb RNA genome that is encapsidated 
by the phosphorylated nucleocapsid (N) protein as a helical nucleocapsid.  The 
viral components assemble at intracellular membranes in the ERGIC 
compartment where they bud into the lumen and are subsequently transported out 
of the cell by exocytosis in cargo vesicles (Palokangas et al. 1998; J. Tooze and 
Tooze 1985).  The roles of the M and S proteins are well defined.  The M protein 
with its three transmembrane domains and ~100 amino acid endodomain tail 
forms a lattice network that makes up the bulk of the envelope.  Through 
interactions with itself, S and the nucleocapsid, M plays a required role in 
organizing the envelope for particle assembly.  The S protein is interspersed in the 
M lattice and extends from the envelope to form the characteristic spikes that 
function to bind cellular receptors and facilitate entry during infection. Only a few 
molecules of the E protein are actually present in virus particles, even though it is 
expressed well during infection.  The function(s) of E during virus assembly are 
much less well defined than for the other protein, but it is well established that the 
protein plays an important role(s) in coronavirus production (Bos et al. 1996; 
Corse and Machamer 2000; Vennema et al. 1996).  
 E proteins are small (~8-10 kDa) hydrophobic viroporins (Wilson et al. 
2004; Wilson, Gage, and Ewart 2006).  They are expressed well during infection, 
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despite being underrepresented in the viral envelope. All coronavirus E proteins 
contain two distinct structural domains, a longer than typical hydrophobic domain 
and a charged cytoplasmic tail, but the proteins exhibit amino acid sequence 
variability.  E proteins from other coronaviruses can replace MHV E when its 
gene is deleted, suggesting that the proteins provide a common function that is 
interchangeable among the viruses (Kuo, Hurst, and Masters 2007).  Surprisingly, 
a truncated variant of the M protein was recently shown to enhance the growth of 
MHV lacking the E gene (Kuo and Masters 2010).  Thus, it is apparent that much 
remains to be understood about the mechanistic role(s) coronavirus E proteins. 
E and M proteins are sufficient and necessary for virus-like particle (VLP) 
production for most coronaviruses, even though addition of the N protein can 
enhance VLP output in some cases (Bos et al. 1996; Corse and Machamer 2000; 
Vennema et al. 1996; Siu et al. 2008; Boscarino et al. 2008; Arndt, Larson, and 
Hogue 2010).  Severe acute respiratory syndrome coronavirus (SARS-CoV) VLP 
production appears to be most efficient when M, N and E proteins are co-
expressed (Siu et al. 2008).  However, expression of only M and N or M and E 
have both been reported to be sufficient for SARS-CoV VLP release from cells 
and expression of M alone has been reported to form extracellular vesicles that 
are less dense than VLPs (Y. Huang et al. 2004; Hatakeyama et al. 2008; Hsieh et 
al. 2005; Tseng et al. 2010). Deletion of the E gene from the viral genome results 
in variable decrease in virus yields that ranges from almost no virus output in the 
case of MHV to only modest reduction that is cell type dependent in the case of 
SARS-CoV (Ortego et al. 2007; Kuo and Masters 2003; DeDiego et al. 2007). 
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When E is deleted from transmissible gastroenteritis coronavirus (TGEV) virions 
assemble, but are blocked as immature particles in the secretory pathway (Ortego 
et al. 2007). 
 A number of coronaviruses E proteins have been shown to form ion 
channels in lipid bilayers that transport cations (Na+ or K+) (Wilson et al. 2004; 
Wilson, Gage, and Ewart 2006) and recently ion channel activity was measured in 
transfected cells expressing SARS-CoV E (Pervushin et al. 2009).  The relevance 
of presumed ion channel activity during virus infection remains to be shown, but 
consistent with a possible role of the activity, disruption of the hydrophobic 
domain of MHV E or replacement of the transmembrane domain (TMD) of 
infectious bronchitis virus (IBV) with a heterologous TMD results in decreased 
virus production and defects in release of virions from cells (Ye and Hogue 2007; 
Ruch and Machamer 2011). All Coronavirus E proteins are presumed to 
oligomerize since they form ion channels in lipid bilayers.  Computational 
modeling of SARS-CoV E hydrophobic domain and subsequent nuclear magnetic 
resonance (NMR) analysis indicates that the domain forms pentameric alpha-
helical bundles (Liao et al. 2006; Torres et al. 2006; Pervushin et al. 2009). 
E proteins have been reported to localize in the ER, ERGIC and Golgi, as 
well as on the cell surface (Raamsman et al. 2000; Corse and Machamer 2000; 
Lim and Liu 2001; Teoh et al. 2010; Tseng et al. 2010). Since E is significantly 
underrepresented in mature virus particles, yet expressed well during infection, 
we sought to better define its localization and expression dynamics to help further 
our understanding of its mechanistic role(s) in virus assembly and egress or other 
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roles that it may play during infection.  We show that MHV E localizes both in 
the ERGIC and Golgi and that the protein does not traffic to the cell surface. The 
protein is oriented with its carboxy end on the cytoplasmic side of the membranes 
and the amino end on the luminal side. Using a recombinant genetically 
engineered MHV that expresses a TC tagged E, the protein was monitored in real-
time during infection to determine that it is not highly mobile in ER/ERGIC 
membranes.  Additionally, CLEM analysis allowed E to be visualized directly in 
Golgi stacks.  The results strongly support the notion that E function(s) at the 
intracellular site of assembly. This is the first report to describe live-cell imaging 
of a coronavirus E protein that expands opportunities to analyze interplay between 
E and cells to help further our understanding of its functions during infection. 
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MATERIALS and METHODS 
Cells and viruses. Mouse 17 clone 1 (17Cl1) and L2, baby hamster kidney 
(BHK-21) and human 293T cells were maintained as previously described (Arndt, 
Larson, and Hogue 2010).  Wild type (WT) and recombinant MHV A59 virus 
stocks were grown in 17Cl1 cells at specified multiplicities of infection (MOI) 
and virus titers were determined in L2 cells.  
Generation of TC-tagged E proteins. MHV E and tagged forms of the gene 
were expressed in the pCAGGS vector under the control of the chicken β-actin 
promoter as described previously (Lopez et al. 2008).  pCAGGS E-Lumio was 
constructed by PCR amplification using pCAGGS E as the template and 
appropriate primers that included the coding sequence for the tetracysteine tag 
(CCPGCC) and two preceding codons for alanine and serine in the reverse 
primer.   The chimeric E – VSV TMD Lumio construct was generated by 
replacing the TMD of MHV E (QIIFIFAVCLMVTIIVVAFLASI) with the TMD 
of VSV G (SSIASFFFIIGLIGLFLVL) by serial PCR with appropriate primers.   
Construction of recombinant MHV with TC tagged E. Recombinant MHV E 
Lumio was made by reverse genetics using a MHV A59 clone (Yount et al. 2002).  
The coding sequence for WT E was replaced in the G clone with TC-tagged E as 
described above by three-way ligation of PCR amplified fragments covering the E 
gene locus and flanking regions. Following sequence confirmation of the 
subcloned region between Sbf I and Nde I restriction sites and junctions after 
ligation into the G clone, a full-length cDNA genomic clone was assembled, 
transcribed and electroproated into BHK-MHVR cells as described previously 
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(Verma et al. 2006). Viruses were recovered, plaque purified, passaged and 
stability of the TC tag was confirmed after at least five passages.    
Indirect Immunofluorescence. Mouse 17Cl1, hamster BHK-21 or human 293T 
cells were plated either on Nunc Lab-Tek chamber slides or coverslips (No. 1.5) 
in multiwell plates 1 day prior to use.  Cells were infected at the specified MOIs 
or transfected using TransIT-LT1 transfection reagent (MirusBio LLC, Madison, 
WI). At the specified times cells were washed with phosphate-buffered saline 
(PBS) and fixed with 100% methanol for 15 min at -20o C for internal staining.  
Cells were washed with PBS and blocked with 0.2% gelatin in PBS for 1 h at 
room temperature (RT) or overnight at 4o C.  For surface staining cells were 
washed two times with PBS and fixed in freshly prepared 3% paraformaldehyde 
in PBS for 15 min at RT, followed by quenching with 10mM glycine for 15 min.  
Cells were permeabilized with 0.1 % Triton X-100 in PBS for 3 min for parallel 
internal staining, followed by washing and blocking with gelatin as described 
above. For digitonin permeabilization, cell chamber slides were placed on ice and 
rinsed in KHM buffer containing 110mM potassium acetate, 20 mM HEPES (pH 
7.2) and 2 mM magnesium acetate. Cells were permeabilized with 25 μg/ml of 
digitonin in KHM buffer on ice for 5 min, followed by two washes in PBS. Cells 
were fixed in 3% paraformaldehyde and quenched as described above.  
 Cells were incubated with appropriate primary antibodies for 2 h at RT, 
washed multiple times with 0.2% gelatin in PBS before incubation with Alexa 
Fluor-labeled secondary antibodies (Invitrogen).  Cells were washed several times 
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in PBS containing 0.2% gelatin, once with PBS alone and mounted in ProLong 
Gold antifade reagent (Invitrogen).  In most cases nuclei were stained with 4,6-
diamino-2-phenylindole (DAPI) prior to mounting.  Images were viewed using an 
epifluorescence Nikon inverted microscope (Nikon Inc., Melville, NY) with 
MetaMorph imaging software (Universal Imaging Corporation, Downingtown, 
PA).  Image processing was performed using Adobe Photoshop.  Laser scanning 
confocal microscopy was done using the Zeiss LSM 510 META microscope and 
software (Carl Zeiss, Inc., Thornwood, NY). Images were processed using Image 
J software (Rasband WS 1997-2011; Abramoff, M.D., Magalhaes, P.J. and Ram, 
S.J 2004). 
 Primary antibodies used in this study included rabbit polyclonal 9410 
generated in the Hogue Lab against the carboxy terminal 21 amino acids of MHV 
E coupled to keyhole limpet hemocyanin (KLH).  Mouse monoclonals J1.3 and 
2.7 were previously described  and polyclonal antibody A04 against MHV S was 
kindly provided by Kathryn Holmes, University of Colorado Health Sciences. 
Biotinylation of surface proteins. Mouse 17Cl1 cells were plated on 60mm cell 
culture dishes (BD Biosciences) 1 day prior to use. Cells were infected at a MOI 
of 0.1. At 8, 12 and 16 h p.i. the media was aspirated and cells were washed twice 
in PBS. Cells were incubated on ice with 1 mg/ml biotin (Thermo Fisher 
Scientific) for 1 h.  Cells were washed twice in PBS and biotin was quenched with 
50mM glycine in PBS for 5 min. Cells were lysed in biotinylation lysis buffer 
containing 10mM HEPES (pH 7.2), 0.2 % NP-40, 150mM NaCl containing 
protease inhibitor cocktail (Sigma, St. Louis, MO) at 0°C for 10 min. Lysates 
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were clarified at 16,000 X g for 10 min at 4oC.Streptavidin agarose resin  
(ThermoFisher Scientific) was equilibrated in biotinylation lysis buffer and added 
to the cell lysate. Binding was carried out at 4oC with constant rotation. The 
Streptavidin agarose resin was pelleted at 4,000 X g for 10 min at 4oC.  
Biotinylated surface proteins were eluted from the agarose resin in Laemmli 
sample buffer by heating at 100o C. Ten percent of the intracellular fraction and 
40% of the surface fraction were loaded onto SDS-PAGE gels and subsequently 
analyzed by Western blotting.  
Immunogold labeling: Mouse 17cl1 cells were infected at an MOI of 5. Cells 
were fixed at 6 h p.i. in 2% formaldehyde and 2% glutaraldehyde in 0.1 M 
phosphate buffer pH 7.6 for 1 hour at room temperature. Cells were scraped into a 
pellet and processed for immunogold labeling. The pellet was serially dehydrated 
in increasing concentrations of ethanol and embedded in increasing 
concentrations of LR White resin (London Resin Company). The pellet was 
sealed in a plastic bullet in the absence of air and allowed to polymerize at 550C 
for 48 hours. The pellet was excised from the plastic bullet, trimmed and serially 
sectioned into 70 nm sections. Sections were collected on formvar coated Nickel 
grids. Grids were then incubated with a rabbit anti E antibody (1:50 dilution) for 2 
hours in PBS with 0.5 % gelatin. The grids were incubated further with a 
secondary antibody (Goat anti rabbit IgG conjugated to 10 nm gold beads- 
Sigma). After the incubation with the antibodies, the grids were stained with 0.5 
% uranyl acetate for 30 seconds and observed under the transmission electron 
microscope.  
  39 
Live cell imaging. Mouse 17Cl1 cells were grown in glass bottom 35 mm dishes 
(MatTek) and subsequently infected at a MOI of 0.1 with MHV E Lumio virus. 
At 7 h p.i.cells were washed in serum free Opti-MEM and labeled with 200 
nMLumio Green (FlAsH) reagent (Invitrogen) in Opti-MEM for 30 min at 37o C 
in the presence of CO2.  Cells were washed thoroughly with Opti- MEM, re-fed 
with 1X MEM without phenol red, plus 200 nM disperse blue for background 
reduction and allowed to recover for 30 min at 37o C.  Cells were monitored and 
imaged using a Zeiss LSM 510 META Confocal Microscope with the 488 nm 
laser at 5% power in a humidified chamber supplied with CO2 and equipped with 
a heated stage and objective.  Images were captured every 10 min over a 3 h 20 
min time course with Z-sections of 0.5 μm.   
Fluorescence recovery after photobleaching (FRAP). Mouse 17cl1 cells were 
grown in glass bottom 35mm dishes (MatTek) and infected with MHV E Lumio 
virus at a MOI of 0.1. Cells were stained with 200 nM Lumio Green (FlAsH) 
reagent (Invitrogen) and imaged as described above. Individual cells were 
selected for FRAP analysis. Selected regions were photobleached with a 488 nm 
laser at 100% power and recovery was measured every 5 sec for 5 min. Initial 
signal intensity was set as 100% and signal recovery was calculated accordingly. 
Mobility fraction was calculated as the percentage of fluorescence recovery from 
what was measured immediately following photobleaching.  
Correlative light electron microscopy (CLEM). Mouse 17Cl1 cells were grown 
on 35 mm gridded glass bottom dishes (MatTek). Cells were infected with MHV 
E Lumio virus at a MOI of 0.5 pfu/cell.  At 8 h p.i. cells were washed twice with 
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Opti-MEM and labeled with 200 nM Lumio Red (ReAsH) reagent (Invitrogen) in 
Opti-MEM.  Cells were incubated for 30 min in the presence of CO2.  After 
washing, cells were refed with Opti-MEM containing 0.5 μM 2,3-dimercapto-1-
propanol plus 20 mM DTT and incubated in the presence of CO2 for an additional 
30 min.  Cells were washed to remove all traces of DTT and refed with 1 ml of 
1:1 DMEM:Opti-MEM containing 2.5% fetal calf serum. Cell images were 
collected using a Zeiss LMS 510 META Confocal Microscope.  
 For photoconversion after labeling with ReAsH, cells were fixed with 2% 
glutaraldehyde in 100mM sodium cacodylatebuffer (pH 7.4) and incubated for 30 
min at 37oC.  Cells were rinsed in 100mM cacodylate buffer and treated for 5 min 
with blocking buffer (100mM cacodylate buffer (pH 7.4) supplemented with 
10mM potassium cyanide, 10mM aminotriazole, 0.01% hydrogen peroxide and 
50mM glycine).  After rinsing with blocking buffer a solution of 1 mg/ml 
diaminobenzidine in 100mM cacodylate buffer (pH 7.4) was added to cells.  
Photoconversion was performed using intense illumination (75 W xenon lamp 
without neutral density filters) focused through the 10X microscope objective.  
Cells of interest for further electron microscopy analysis were identified by their 
location on the gridded coverslips.  
Cells were washed with 0.1 M phosphate buffer (pH 7.4) before being fixed with 
a mixture of 1% osmium tetroxide and 0.8% potassium ferricyanide in distilled water for 
1 h at 4oC.  Cells were stained with 2% uranyl acetate in water for 1 h and dehydrated 
through a series of increasing concentrations of acetone for 10 min each at RT. Resin 
infiltration with epoxy TAAB 812 (Electron Microscopy Sciences, Hatfield, PA) was 
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carried out by increasing the resin to acetone ratio from 25% to 100% and polymerization 
at 60o C for 48 h.  Previously selected cells were sectioned at 70 nm and collected on 
formvar coated copper grids. Images were collected on a Philips 80kV STEM microscope 
and processed using ImageJ software (Rasband WS 1997-2011; Abramoff, M.D., 
Magalhaes, P.J. and Ram, S.J 2004). 
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Figure 6: MHV E localizes in the ERGIC and Golgi.  
 
Mouse 17cl1 cells were infected with MHV A59 at a MOI of 1 and 
analyzed at 6 h p.i. (A) Cells were processed for dual-label immunofluorescence 
detection of E and protein disulfide isomerase (PDI) (Alexis), ERGIC-53(Alexis), 
or mannosidase II (Mann-II) (Covance), as ER, ERGIC, and Golgi markers, 
respectively.  The bottom panels were probed for M and E proteins using rabbit 
polyclonal anti-E 9410 and mouse monoclonal J1.3 and J2.7 antibodies, 
respectively. Alexa fluorophore tagged secondary antibodies (Molecular Probes) 
were used to counter stain the primary antibodies. Merged images are shown in 
the far right column, with enlarged insets of selected cells.  Epifluorescence 
images were taken using a 60X objective. (B) Cells were processed for dual-label 
immunofluorescence detection using antibodies specific for E (9410)  andcis 
Golgi  GM 130 (Santa Cruz Biotechnology Inc.), medial Golgi Mann-II 
(Covance) or trans Golgi p230 (GE Healthcare). Confocal images were taken with 
a 100X objective.  
Data in panel A was generated by Dr. Lisa A. Lopez and submitted by LL to 
Arizona State University in partial fulfillment for the requirememts of the PhD in 
Molecular Cellular Biology. 
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RESULTS 
MHV-A59 E localizes in the ERGIC and Golgi. To identify the cellular 
localization of E protein in infected cells, 17Cl1 mouse cells were infected with 
WT MHV A59.  During infection, as early as 6 h p.i. , MHV E exhibited compact 
localization adjacent to the nucleus that clearly did not overlap with the ER 
marker, protein disulfide isomerase (PDI) (Fig. 6A).  Instead, the protein co-
localized with markers of both the ERGIC and Golgi structures (middle two 
panels).  Cells dual labeled for M and E exhibited complete overlap of the signals 
from the two proteins (lower panels).   
To determine the distribution of the E protein in the Golgi, colocalizations 
with cis-Golgi GM-130, medial-Golgi Mann–II and trans-Golgi p230 were 
examined (Fig. 6B). E colocalized most extensively with the cis- and medial-
Golgi markers and less so with the trans-Golgi marker p230. Altogether these 
results clearly define MHV E localization during infection in both the ERGIC and 
Golgi, with it being concentrated primarily in the cis and medial regions of the 
latter.   
MHV E does not traffic to the cell surface. To further address localization and 
trafficking of E, protein expression was examined in cells during a time course 
following infection.  S and M proteins were analyzed in parallel. At 8h p.i. E and 
M continued to colocalized as we had observed at 6h p.i. (Fig. 7A).  Interestingly, 
by 12h p.i. the M protein was localized in areas of the cell distant from the 
ERGIC/Golgi region, whereas E remained localized at perinuclear sites.  
Additionally, E did not localize with the M or S proteins distant to the perinuclear 
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sites when all three proteins were analyzed at 12 h p.i. (data not shown).  By 16 h 
p.i., and more prominently at 24 h p.i., a large portion of the M protein was 
visualized throughout the cytoplasm, presumably as virus output increased.  In 
contrast, at the late time points E continued to remain localized primarily in the 
ERGIC/Golgi region.  Only a few small punctate dots were seen outside of these 
regions, presumably due to the extensive fusion that is characteristic of MHV A59 
infected cells at late times after infection.  These results indicate that E and M 
colocalize at the ERGIC/Golgi assembly site early during infection and E remains 
there at later times as virions and S traffic toward the cell surface.    
 Previous reports suggested that coronavirus E proteins localize to the cell 
surface during infection. To further examine this, cells infected or transiently 
expressing E were analyzed for surface expression (Fig. 7B).  The S and M 
proteins were monitored in parallel as positive and negative controls, respectively, 
for surface expression.  Two approaches were used to monitor surface expression.  
First, 17cl1 cells were infected with WT MHV A59 and proteins on the cell 
surface were biotinylated at 8, 12, and 16 h p.i.  Surface and intracellular fractions 
were then analyzed by Western blotting for the viral proteins.  As expected, S was 
detected in both the intracellular and surface fractions, characteristic of a protein 
that transports through the exocytic pathway.  The M protein was also detected in 
both fractions at later time points, whereas E was detected only in the intracellular 
fraction at all times.  
Surface staining was also analyzed by immunoflouresence (Fig. 7C).  
Again, 17cl1 cells were infected with MHV and probed with specific antibodies 
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for S, M or E proteins after cells were permeabilized with digitonin or TX-100 to 
reveal the cytoplasmic or both luminal and cytoplasmic epitopes, respectively. 
The amino end of the M protein was recognized by monoclonal antibody J1.3 in 
the perinuclear region after cells were permeabilized with TX-100, but not with 
digitonin, consistent with the orientation of the protein at intracellular membranes 
and its known localization. The E protein was not detected in a perinuclear region 
in both TX-100 and digitonin treated cells when probed with antibody 9410 that 
recognizes the carboxy terminus.  This indicates that the carboxy end is located on 
the cytoplasmic side of internal membranes.  No signal was thus visible in non-
permeabilized cells. Since antibodies that recognize the amino were not available, 
we made use of a construct with a Strep tag appended on the amino end to 
determine if the protein traffics to the cell surface (Fig. 7D).  VLPs can be 
assembled with the Strep-tagged E (data not shown), thus we reasoned that it 
would provide a relevant assessment for whether the amino end is accessible at 
the cell surface.  BHK-21 cells were transfected with the pCAGGS vector 
containing the Strep-tagged E gene. The amino and carboxy ends of E were 
detected with Strep tag-specific or 9410 antibodies, respectively.  The results 
clearly showed that indeed the amino end is not exposed on the cell surface.   
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Figure 7: MHV E does not traffic beyond the site of assembly. 
(A) 17Cl1 mouse cells were infected with MHV A59 at a MOI of 1 and 
fixed indicated times.  Indirect immunofluorescence was used to probe for E 
(green) and M (red) proteins. (B) 17cl1 cells were infected with MHV at an MOI 
of 0.1. At 8, 12 and 16 h p.i., surface proteins were biotinylated. Surface and intra 
cellular proteins were analyzed for S, M and E by Western Blotting. (C) 17cl1 
mouse cells were infected with MHV at an MOI of 0.1 and probed for S, M and E 
with digitonin or TX-100 to reveal the cytoplasmic or both luminal and 
cytoplasmic epitope of the protein. (D) BHK-21 cells were transfected with 
pCAGGS DNA expressing MHV E with a Strep- tag at the amino end. The amino 
and carboxy ends of E were detected with an anti-Strep monoclonal, StrepMAB-
Classic (IBA) and rabbit anti-E 9410 antibodies, respectively. 
Data in panel A was generated by Dr. Lisa A. Lopez and submitted by LL to 
Arizona State University in partial fulfillment for the requirememts of the PhD in 
Molecular Cellular Biology. 
 
 
 
 
  49 
 
Figure 8: MHV E localizes to membranes around assembled virions 
17cl1 cells were infected at an MOI of 5 and fixed at 6 h p.i. Samples were 
processed for immunogold labeling and stained against antibodies for E. The 
arrows indicate gold beads (10nm) and arrowheads indicate fully assembled 
virions. 
 
 
 
 
  50 
MHV E localizes to membranes around assembled virions. To identify the 
ultrastructural localization of E in infected cells, we performed immunogold 
labeling on cells infected with the MHV A 59 virus.  We infected cells at a high 
MOI and fixed it at an early time post infection. This would prevent the extensive 
membrane remodeling that occurs at late times post infection. We were able to 
detect antibodies against E consistently localizing to membranes around fully 
assembled virions (Fig 8). This was consistent with previously known information 
about E, where very few molecules of E are present on assembled virions with the 
majority of E present in membranes at the region of assembly. 
Generation of MHV with a tetracysteine (TC)-tagged E protein. To 
investigate the dynamics of E expression in live cells, we constructed a 
recombinant E protein with a TC tag (CCPGCC) appended at the carboxy end.  
TC tags form hairpin structures that bind small, membrane-permeable fluorescein 
derivatives such as the fluorescein arsenical hairpin binder (FlAsH) or a variant, 
resorufin arsenical hairpin binder (ReAsH), a red-shift analog. The biarsenicals 
are fluorescent when they bind to TC tags.  We initially confirmed that the tagged 
E could support VLP formation (data not shown) and that the protein localized 
correctly in the ERGIC/Golgi (Fig. 9A).  A chimeric TC-tagged E with the TMD 
replaced by that of VSV G was previously constructed for other purposes, thus we 
took advantage of the opportunity to determine where it localized as well.  The 
chimeric protein also localized in the ERGIC and Golgi like the WT protein, 
which suggests that the signal for intracellular localization is likely in the carboxy 
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terminal domain of E, even though contribution of the short nine residue amino 
terminus cannot be ruled out (Fig. 9B) 
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Figure 9: Characterization of TC-tagged E and recombinant MHV with 
tagged E. 
Schematics indicate location of TC tag at the carboxy ends of WT E or a 
chimeric E gene with the TMD replaced by the TMD of VSV G protein. (A) 293T 
cells were transfected with pCAGGS-MHV-E Lumio, fixed at 8 h post 
transfection and processed for indirect immunofluorescence to detect E (green), 
and ER, ERGIC or Golgi (red) markers as indicated in middle images. Yellow in 
the merged panels indicates co-localization of signals from the two channels.  (B). 
293T cells were transfected with pCAGGS vector containing the E-VSV TMD 
chimeric gene, fixed at 8 h after transfection and processed for indirect 
immunofluorescence as described above.  (C). 17Cl1 mouse cells were infected 
with WT (top) or E Lumio (bottom) viruses at a MOI of 1.  Cells were labeled 
with Lumio Red  (ReAsH) at 8 h p.i., fixed and stained for E.  Yellow in the 
merged panels indicates co-localization of ReAsH and E. Inserts show magnified 
images of a representative cell.  (D). Growth kinetics and plaque characteristics of 
WT and E Lumio viruses were analyzed in 17Cl1 mouse cells infected at a MOI 
of 0.01. Titers were determined by plaque assay on L2 cells at the indicated times.    
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Having determined that the tag does not interfere with localization of the 
protein, we then constructed a recombinant MHV A59 with the WT E gene 
replaced by the TC-tagged form.  The recombinant virus, designated as MHV E-
Lumio was easily recovered. Colocalization with the anti-E antibody in infected 
cells demonstrated specificity of the ReAsH staining. The TC-tagged E from the 
virus co-localized specifically with the signal produced by anti-E recognition of 
the protein (Fig. 9C).  However, the E-Lumio virus did produce smaller plaques 
and growth kinetic analysis showed that the virus grew slower, yielding titers that 
were ~100-fold less than the WT untagged virus by 20 h p.i. (Fig. 9D). 
Nonetheless, the tag was stably retained when analyzed through five passages. 
This indicated that MHV E Lumio was replication and assembly-competent and 
thus, a good model to study, for the first time, the dynamics of the protein in live 
infected cells.   
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Figure 10: MHV E Lumio virus allowed live cell imaging of the E protein 
during infection.  
FRAP was performed on MHV E Lumio in 17cl1 cells at 8 h p.i. FRAP 
analysis revealed that the E protein was dynamic in the membrane and among all 
the cells observed, four different recovery trends were observed (n= 14). An 
example of each recovery trend along with the corresponding images are shown in 
Figures 10B and 10A. The E protein has a wide range of mobility fractions 
ranging from 41- 87% with an average of 61% (n= 14) (10C- top). While the 
mobility fraction revealed that the E protein was mobile, the rate of recovery was 
wide, ranging from 10 s to 200 s (10C bottom). The mobility fraction and time 
constant of recovery for the four shown images are indicated on the graphs.  
Long-term analysis (200 min) of the dynamics of the E protein revealed that the 
protein remained at the site of assembly and further suggested that the E protein 
did not traffic to the cell surface. 
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Live-cell imaging of E protein in infected cells. MHV E Lumio virus allowed 
live cell imaging of the E protein during infection. Flourescence Recovery After 
Photobleaching (FRAP was performed on MHV E Lumio in 17cl1 cells at 8 h p.i. 
FRAP analysis revealed that the E protein was dynamic in the membrane and 
among all the cells observed, four different recovery trends were observed (n= 
14). An example of each recovery trend along with the corresponding images are 
shown in Figures 10B and 10A. The E protein has a wide range of mobility 
fractions ranging from 41- 87% with an average of 61%. (n= 14) (10C- top). 
While the mobility fraction revealed that the E protein was mobile, the rate of 
recovery was wide, ranging from 10 s to 200 s (4C bottom). The mobility fraction 
and time constant of recovery for the four shown images are indicated on the 
graphs.  Long term analysis (200 min) of the dynamics of the E protein revealed 
that the protein remained at the site of assembly and further suggested that the E 
protein did not traffic to the cell surface. 
Correlative Light Electron Microscopy of E protein in infected cells. A TC 
tag allows for proteins to be imaged directly in live cells, as described above, but 
it also offers the advantage that following addition and photoconversion of 
diaminobenzidine (DAB) that the same cells can be analyzed by electron 
microscopy (EM).  Cells infected with MHV E-Lumio were initially viewed by 
confocal microscopy after addition of the biarsenical reagent ReAsH (Fig. 11A).  
Photoexcitation of ReAsH bound to a TC tag results in release of singlet oxygen, 
which in turn polymerizes added diaminobenzidine (DAB). The precipitate that 
forms can be visualized directly by EM following osmimum tetroxide staining.  In 
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MHV E-Lumio virus infected cells a precipitate was visible that co-localized with 
ReAsH labeling, as expected in a perinuclear position, consistent with the 
ERGIC/Golgi localization described earlier. When examined by EM the electron-
dense precipitate was localized in Golgi stacks (Fig. 11B).  In some cells Golgi 
fragmentation was evident and E was associated with~20-nm vesicles apparently 
derived from the stacks (data not shown). 
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Figure 11: CLEM of TC-tagged E in infected cells.  
Mouse 17Cl1 cells were infected with MHV E Lumio virus at a MOI of 1. 
(A) At 8 h p.i., cells were stained with ReAsH (left), followed by photo 
conversion (right). (B) A low-magnification electron micrograph of the cell on the 
lower right in A is shown after photo conversion. The electron dense region 
corresponding to the Golgi region is boxed. (C) Higher magnification shows 
electron density in Golgi stacks indicated by the arrows adjacent to the nucleus 
(N).  Scale bars = 1 μm and 50 nm, respectively, for B and C images. 
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DISCUSSION 
 Coronavirus E proteins are clearly important for virus assembly and 
egress, but their mechanistic role(s) is still not understood.  Genetic approaches 
have been used to examine contributions of various conserved residues and 
domains to gain insight about the function of the protein.  Many of the alterations 
significantly impact virus production and transport out of the cell. The 
interchangeable nature of the E proteins, at least in the context of MHV, supports 
the idea that sequence-specific interactions are not required for E to function 
during infection. This raised questions about the localization of E relative to the 
other viral proteins, particularly the M protein, during virus infection.   
Earlier work concluded that MHV E accumulates in pre-Golgi 
membranes, based on its presence in electron-dense convoluted membrane 
structures that co-localized with Rab-1, a marker characteristic of ER and ERGIC 
compartments. Our confocal imaging, in parallel with a full panel of exocytic 
pathway cellular markers, clearly shows that MHV E is not in the ER, but is 
present in both the ERGIC and Golgi, primarily in the cis and medial cisternae of 
the latter, early during infection. Based on the apparent similar roles that the E 
proteins play in virus assembly, it stands to reason they likely share common 
localization characteristics. IBV and SARS-CoV E proteins were previously 
reported to localize in the ER and/or Golgi. Tagged constructs, over expression 
and limited parallel localization with cellular marker proteins were used to draw 
conclusion in some of these studies. Recent studies have more clearly and 
definitively shown that SARS-CoV E co-localizes with ERGIC-53 in infected 
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cells and also when expressed transiently. Strong transient expression of SARS-
CoV E in the cis-Golgi, but hardly any expression in the ERGIC and trans-Golgi 
was also recently reported. We previously showed as well that HA-tagged SARS-
CoV E localized in both the ERGIC and Golgi during transient expression.  
Collectively, it appears that we can conclude that coronavirus E proteins are 
expressed in both ERGIC and Golgi compartments, though the distribution may 
vary depending on the virus and cell type.   
Targeting information was previously mapped to the cytoplasmic tails of 
both IBV and SARS-CoV E proteins using chimeric proteins in which the 
ectodomains and TMDs were replaced by that of VSV G protein.  Our result with 
a similar chimeric protein also suggests that the cytoplasmic tail of MHV E 
contains targeting information. However, since only the TMD was replaced in our 
chimera, we cannot exclude the possibility that additional targeting information is 
present in the amino-terminal region of MHV E. The presence of additional 
targeting information was also suggested when only the cytoplasmic tail of 
SARS-CoV E was replaced by that of VSV-G and the chimeric protein still 
targeted to the Golgi. 
 Previous studies reported that coronavirus E proteins traffic to the cell 
surface. In addition to surface immunofluorescence, cellular permeabilization by 
E proteins and whole-cell patch clamp measurement of ion channel activity in 
cells expressing SARS-CoV E were also suggestive of surface expression.  We 
did not detect MHV E on the surface of non-permeabilized transfected or infected 
cells.  This is consistent with the recent report, which clearly demonstrated that 
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SARS-CoV E is not present at the plasma membrane.  Our confocal microscopy 
analysis over a time course following infection strongly illustrates that E remains 
in its perinuclear location even late during infection.  Results from our live-cell 
and CLEM imaging also support the conclusion that MHV E remains at the site of 
assembly in ERGIC/Golgi membranes and does not transport to the plasma 
membrane.  Our surface expression results yielded additional information 
confirming that MHV E assumes an orientation with the amino end located in the 
lumen and the cytoplasmic tail in the cytoplasm, consistent with the recently 
described topology SARS-CoV E.  The cytoplasmic tail of MHV E was 
previously determined to reside in the cytoplasm, but with a flag tag placed at the 
amino end it was suggested that the protein spans the lipid bilayer twice with both 
the amino and carboxy ends in the cytoplasm.  
 Live-cell imaging was only recently used to follow trafficking and 
dynamics of coronavirus proteins.  Fluorescent tags, such as GFP or mCherry 
were appended to nsp2, nsp4 or N proteins to study replication-transcription 
complexes and their relationship to formation of membrane structures in virus 
infected cells. Results from our live cell imaging and FRAP analysis of MHV E 
Lumio show that TC tagged E is mobile at internal membranes of infected 17Cl1 
cells.  The average mobility (Mf = 61%) of E is similar to what was measured for 
nsp4 in ER membranes. Nsp4 is a nonstructural integral membrane protein that 
localizes to the ER, but the protein is recruited during infection to replication 
complex structures that are interconnected with ER membranes, where its 
mobility (Mf = 33%) is apparently restricted. The mobility of GFP tagged N and 
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nsp2, both soluble cytoplasmic proteins, were also analyzed in cells infected with 
recombinant MHVs expressing the tagged constructs.  The N protein (Mf = 
40.4%) is dynamically associated with replication-transcription complexes, 
whereas nsp2 (Mf = 9.9%) is thought to be immobilized through protein-protein 
interactions in the complexes in infected cells.  
The E protein displayed a range of motilities (Mf = 41 – 87%) at 6 h p.i., 
the point at which virus assembly is actively ongoing. Several factors may 
account for the Mf range.  The population of E molecules that are actively 
involved in assembly maybe associated with other structural proteins or possibly 
host factors that differently restrict lateral diffusion in membranes.  The E protein 
assembles into oligomeric ion channels that could affect the proteins mobility.  
Possibly only a fraction of molecules exists as a component of the channels.  The 
E protein is palmitoylated. We do not know if all potential cysteine residues are 
modified at any given time or if possibly the protein undergoes dynamic 
palmitoylation/ depalmitoylation cycling during infection.  The conserved 
cysteines are located adjacent to the transmembrane domain, which when 
palmitoylated may influence interaction of the protein tail with membranes and 
thus, its diffusion. The HA protein of influenza virus is a transmembrane protein 
that is both palmitoylated and myristoylated. Recent data shows that YFP tagged 
HA has different diffusion coefficients that vary based on the acylation state of 
the protein. WT HA- YFP has a diffusion coefficient of 0.14um/s2 while an 
unacylated mutant has a diffusion coefficient of 0.30um/s2. The acylation greatly 
reduces the mobility of the protein. The E protein has been shown to be 
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palmitoylated at three possible cysteine sites. Depending on the number of sites 
palmitoylated, the E protein may have different mobilities. Also, the E protein 
localizes at the ERGIC- Golgi region- an active site of assembly. It is possible 
that the region undergoes rapid changes in the membrane affecting the dynamics 
of the E protein. 
Fluorescently labeled SARS-CoV structural proteins were also expressed 
to study VLP production and trafficking in live cells. VLPs were assembled with 
chimeric N and S proteins containing a fluorescent protein (cyan – eCFP or green 
– eGFP) tag fused at their carboxy termini, but similarly tagged M protein could 
not be incorporated.  Data was not shown, but the authors indicated that the E 
protein did not tolerate addition of the large fluorescent protein tags.  Our study 
highlights the utility and tolerance of the smaller TC tag since we were able to 
generate a recombinant virus with the tag fused to the carboxy end of E. Other 
recombinant RNA viruses, including VSV, HIV, influenza virus and flockhouse 
virus, with TC tagged proteins have also been described recently. 
 Assembly of coronaviruses at intracellular ERGIC membranes was 
established sometime ago. More extensive and higher resolution views of 
ultrastructural changes that occur during replication and assembly were recently 
described. Three membranous structures, including large virion-containing 
vacuoles (LVCVs), tubular bodies (TBs) and cubic membrane structures (CMSs), 
were associated with virus assembly/release. The E protein was present with two 
of these structures, the LVCVs that are derived from ERGIC/Golgi membranes 
and TBs thought to form late in infection as a result of excess protein self-
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aggregation. The latter are thought to be equivalent to previously described 
smooth tubular membranous structures that are induced by E protein expression 
late during coronavirus infection.  During the time frame in which our CLEM 
studies were conducted, we did not detect these tubular structures.  We did find E 
associated with Golgi cisternae and in some cells association with Golgi 
fragmentation was noted.  Golgi fragmentation has been observed by confocal 
microscopy in cells infected with MHV or TGEV and also when IBV E was 
overexpressed.  Golgi disruption was not observed in cells infected with a 
recombinant TGEV lacking the E gene, but fragmentation occurred when E was 
provided in trans, thus providing strong support for contribution of the protein to 
this process.  Our CLEM results illustrate the potential to follow E during 
infection and to monitor changes at the ultrastructural level that are associated 
with the protein, a direction that will be pursued further in future studies.                          
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Figure 12: Schematic illustration of E protein potential roles at its 
localization in ERGIC/Golgi membranes during infection.   
Possible roles include (1) alteration of the luminal environment through 
ion channel activity, (2) alteration of membrane curvature and/or scission, (3) 
interactions with host proteins involved in assembly and/or transport and (4) 
signaling to the plasma membrane (PM) as a result of host protein interactions or 
through ion channel activity.  
N 
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The accumulation of E in ERGIC/Golgi membranes and the fact that only 
a few molecules are incorporated into virions suggests that E likely provides a 
function(s) that is peripheral to or limited at most in the area where virion 
particles bud.  We previously proposed a model for potential mechanisms that E 
may play based on its accumulation in ERGIC/Golgi membranes and our overall 
understanding of E that has accumulated from many studies to date in the field 
(Hogue, B.G. et al., presented at The ninth International Symposium on Positive-
Strand RNA Viruses, Atlanta, GA, 2010; Dolezal, K.A., S.M. Daskalova, B.G. 
Hogue, presented at American Society for Virology 29th Annual Meeting, 
Montana State University, Bozeman, Montana, 2010). Lack of E trafficking to the 
cell surface during infection lends additional support for the protein’s 
participation in virus assembly and morphogenesis and possible other roles during 
infection from its position in the internal membranes as we illustrate in Fig. 12. At 
these membranes E may, through its ion channel transport of cations directly 
influence the immediate microenvironment in the ERGIC lumen by alteration of 
Na+ or K+ concentration that could in turn result in luminal pH changes that are 
balanced by activation of vacuolar H+ATPase.  The ERGIC does contain an active 
H+ATPase that has been suggested to be possibly involved in directional transport 
and concentration of cargo molecules.  A second, previously suggested, 
possibility is that E plays a role in helping mediate membrane curvature or 
scission.  Influenza M2, a well-characterized multifunctional small integral 
membrane protein with proton-selective ion channel activity, plays a significant 
role in entry during infection, but it is also involved in virus assembly.  Recently 
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M2 was shown to mediate membrane curvature and scission during budding.  
Coronavirus E proteins could play a similar role.  Thirdly, coronavirus E proteins 
may, through interactions with host proteins, facilitate virus budding or vesicular 
transport.  A large number of host proteins co-purify with SARS virions and 
recently host and viral proteins that interact with E were identified.  Finally, E ion 
channel activity at internal membranes may result in signaling that activates ion 
channel activity at the cell surface.  While the latter is only speculative at this 
point, measurement of ion channel activity at the surface of cells expressing 
SARS-CoV E might reflect a response to such signaling and while such activity 
might be less likely to play a role in virus assembly and transport of LVCVs, such 
activity could impact a role of the protein as a possible virulence factor during 
infection. SARS-CoV lacking the E gene is attenuated in animal models, thus the 
protein, at least for this virus, may be a virulence factor.  
 Evidence for disruption of protein trafficking by overexpression of IBV 
during MHV infection was recently described.  Based on IBV E modification of 
the secretory pathway, potential roles and mechanisms that the protein may 
provide were discussed, some of which are similar to possibilities we outlined 
above.  It is clear that E protein residence in the ERGIC/Golgi region impacts the 
local cellular environment, which may be linked to possibly multiple roles that it 
plays in virus assembly/release, as well as pathogenesis. The ability to monitor E 
directly in live cells and to extend this to ultrastructural studies using CLEM 
should expand the opportunities to analyze interactions between the protein and 
  69 
the cell during infection to help increase our understanding of its role(s) and 
mechanistically how it functions. 
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Chapter 3 
CONSERVED RESIDUES IN THE TAIL OF THE CORONAVIRUS 
ENVELOPE PROTEIN MAY CAUSE MEMBRANE CURVATURE 
ABSTRACT 
Coronavirus envelope (E) proteins are small membrane viroporin proteins.  
Viroporins are characteristic of many RNA viruses.  Few E molecules are present 
in mature virions, yet co-expression of E and the membrane (M) proteins is 
sufficient for the formation of virus-like-particles (VLPs) of most coronaviruses.  
The roles of E are yet to be fully understood, but it is clear that the protein is 
important for virus assembly and release.  Multiple domains, including the 
transmembrane domain, the charged carboxy end and conserved cysteines are 
recognized contributors to these processes. One important domain contains 
conserved proline and tyrosine resides. The domain is located adjacent to the 
conserved membrane proximal palmitoylated cysteine domain. This strongly 
suggests that the conserved proline residues are important and may contribute to 
the overall structure of the protein that is important for its function(s). We have 
shown that alanine substitutions at these positions in mouse hepatitis CoV (MHV) 
A59 E results in and significant reduction in virus-like particle assembly and 
production of infectious virus particles. However, these mutants are viable in the 
context of infection and produce viruses that are crippled to various extents. The 
conserved domain we have identified may affect the interaction of E with 
membrane lipids. We were able to use peptides encompassing the conserved 
region and study its interaction with lipids. The WT peptide was able to interact 
  72 
well with lipids, reducing their melting temperature. More over, the WT peptide 
was able to significantly reduce the hexagonal phase transition temperature of the 
lipid POPE, thereby causing a local negative membrane curvature. This may play 
a role to initiate or stabilize virion budding and/ or aid in virion scission.  
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INTRODUCTION 
 Coronaviruses are medically important pathogens that belong to the family 
Coronaviridae in the Nidovirales order. The viruses cause primarily respiratory 
and enteric infections in humans and a wide range of animals. The emergence of 
severe acute respiratory syndrome coronavirus (SARS-CoV), subsequent 
discovery of other previously unrecognized human and animal coronaviruses, 
combined with knowledge that some coronaviruses are zoonotic, has increased 
awareness of their medical relevance.  The importance of understanding the 
biology of the large family of viruses and development of treatment and 
preventative measures is clearly warranted.   
Coronaviruses are enveloped, positive-stranded RNA viruses.  Minimally, 
virions consist of four structural proteins, the spike (S), membrane (M), envelope 
(E) and nucleocapsid (N). The M protein has three transmembrane domains, 
flanked by a short extra-virion region and a long carboxy tail that is located inside 
the virion. The protein forms a lattice that forms the overall membrane scaffold. S 
is the receptor attachment protein that mediates virus entry through fusion. The E 
protein is a minor component of the envelope that plays a role(s) in virus 
assembly and release. The N phosphoprotein encapsidates the viral genome into a 
helical nucleocapsid. For murine hepatitis virus (MHV), the M and E proteins are 
minimally required for the formation of virus like particles (VLPs) and for SARS, 
the E, M and N protein are required for the same.  
 The E protein is a small hydrophobic viroporin protein. The overall 
structure of all coronavirus envelope proteins is highly conserved (Fig. 13). A 
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short amino terminus precedes a long hydrophobic stretch, encompassing two- 
thirds of the protein, followed by conserved cysteines, conserved prolines and a 
highly charged carboxy tail. The hydrophobic domain is predicted to form an 
amphipathic helix and the pitch of the helix is vital for the ion channel activity of 
the E protein. The palmitoylation at the conserved cysteines increase protein 
stability. The charge to alanine clusters at the tail of the E protein affect virus 
morphology and thermostability. Upon close analysis of betacoronavirus E 
proteins, it was revealed the presence of an absolutely conserved proline and 
tyrosine (Fig. 13) in the tail of the E protein. Coronaviruses assemble at the 
membranes of endoplasmic reticulum Golgi intermediate compartment (ERGIC). 
The mechanism of virus assembly and budding at internal membranes is poorly 
understood. Also, unlike normal vesicle budding, virions assembly and bud into 
the lumen. It is highly likely that host factors play a role in this process. The most 
characterized host mechanism that allows multivesular body formation is the 
endosomal sorting complex required for transport (ESCRT) pathway and have 
been shown to play a very important role in budding and release of viruses such 
as HIV, Herpes, Ebola and Hepatitis C. The interaction of proteins with members 
of the ESCRT pathway is mediated by the presence of specific sequences called 
late domains, which are rich in prolines and tyrosines. The ESCRT pathway 
regulates protein trafficking using mono- ubiquitination. Recently, SARS E has 
been shown to be ubiquitinated. 
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Figure 13: Alignment of tail of the E protein . 
A schematic of the coronavirus E protein is represented. The hydrophobic domain 
is indicated by the cylinder. Sequence of the MHV –A59 E protein is shown. A 
sequence alignment of the tails of envelope proteins from alpha, beta and gamma 
coronaviridae are shown. Arrows indicate conserved prolines and tyrosine of 
interest. Generated mutants of MHV A 59 E protein are shown, along with the 
mutated residues. 
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Previous studies have shown that the E protein is critical for virus 
trafficking and release. We hypothesized that the conserved proline and tyrosine 
may play a role in virus trafficking and release.  Another proline is highly 
conserved in the tail of the E protein corresponding to position 76 for MHV E. 
This proline may be playing a role in the positioning of the tail of the E protein. 
The overall aim of this paper is to dissect the role of the conserved prolines and 
tyrosine in the tail of the E protein using site directed mutagenesis - reverse 
genetics approach. The paper demonstrates the significance of the conserved 
residue proline 54 and tyrosine 57 in virus assembly and trafficking. This paper 
shows the first biophysical evidence that the tail of E protein may be introducing 
negative curvature in lipids allowing membrane bending possibly during virion 
budding. 
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MATERIALS AND METHODS 
Cells and viruses. Mouse 17Cl1 cells and L2 cells were used to grow WT and 
mutant MHV viruses. Cells were maintained in Dulbecco’s Modified Eagle’s 
Medium supplemented with 5% heat- inactivated fetal calf serum and 1 % 
glutamine, 10 % tryptose phosphate broth and the antibiotics penicillin and 
streptomycin. Human embyronic kidney (HEK) 293 –T (ATCC No. 112678) cells 
were maintained in Dulbecco’s Modified Eagle’s Medium supplemented with 
10% heat- inactivated fetal calf serum and 1 % glutamine. BHK- 21 cells 
expressing the MHV receptor Bgp 1a (BHK- MHV R) were maintained in 
Glasgow’s Modified Eagle’s Medium supplemented with 5 % heat inactivated 
fetal calf serum, 10% tryptose phosphate broth and (amount to be added) 
geneticin (G418) (Dveksler et al., 1991).  
Construction of alanine substitution mutants. pScript E, a pPCR- Script Amp 
SK (+) vector (Stratagene) vector containing the MHV A59 E gene (GenBank 
Accession no: AAF69347.1) was used for mutagenesis. Mutagenesis was 
performed using a whole plasmid PCR approach using appropriate primers, listed 
in table 1, with high- fidelity Pfu polymerase (Stratagene). Following an initial 
incubation at 950C for 5 min, 25 cycles of 950C for 30s, 500C for 60s and 720C for 
12 minutes was applied. PCR products were DpnI treated to remove methylated 
template DNA and transformed into Top 10 competent cells (Invitrogen). 
Mutations were confirmed by sequencing the entire insert and subcloned into the 
MHV G clone at the EcoRV and Sbf1 restriction sites. 
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Table 2: Primers used for mutagenesis, reverse transcription and sequencing 
 
 
 
 
!"#$ %&'#$&()$*+$,-$ .)$ 
/01(2(%345(678 9:::;;:;9:;:99;9;:9:5:::5:::;:5:;5:5;; /.:5;2!2<=< 
/01(2(%345(>21 9555:555:5;59;9;;595;9599555;:5::595:55599 /.:5;2!2<=< 
/01(2(%?@5(678 ;55;55::;5;59:;;9:9:5::5;5;;:;95:;5:5:9 /.:5;2!2<=< 
/01(2(%?@5(>21 9599:9:55:5;5;995;:9:95:::9::95::5::5:5 /.:5;2!2<=< 
/01(2(A3?5(678 ;:;9:;:9999::9:5::;9:::;:5:;5:5;;5;:55;95; /.:5;2!2<=< 
/01(2(A3?5(>21 95:59555;955:5;55;;;;595;9599555;:5::595:55599;555; /.:5;2!2<=< 
/01(2(%345A3?5(678 ;:;9:;:99;99:9:5::;9:::;:5:;5:5;;5;:55;95; /.:5;2!2<=< 
/01(2(%345A3?5(>21 95:59555;955:5;5;;9;;595;9599555;:5::595:55599;9555; /.:5;2!2<=< 
/01(2/(BCD 95;559:;:995595;;99;::5;955; >:E%9>(BCD()F&",G) 
/01(2/(BED ;9559995;55;59599::955:;9 >:E%9>(BED()F&",G) 
/01(/!(BCD 99599:9:595:;955;;:;::55;9 >:E%9>(BCD()F&",G) 
/01(/!(BED ;;:9:;99595599::9:9:5:9: >:E%9>(BED()F&",G) 
/01(2(>$H$&)$ 9;;:599:::95:5:9:5:59 <$*+$,-',I(2(I$,$ 
/01(4(>$H$&)$ 5;:9:;9:::;;9:;5::99::9 <$*+$,-',I(/(I$,$ 
/01(@(>$H$&)$ ::99:;5;99:;:9:59; <$*+$,-',I(/(I$,$ 
/01(?(>$H$&)$ 5::9:;;:;;:;9:;5:;5599;;9 <$*+$,-',I(!(I$,$ 
/01(J(>$H$&)$ ;;95;55;9:99:9:;:55599 <$*+$,-',I(!(I$,$ 
%<(%9>(6K&L"&G :5::;59;:;:;9:;;59:959 %"-M"I',I()'I,"N 
%<(%9>(&$H$&)$ 95:55995;;:::995;:95;9 %"-M"I',I()'I,"N 
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Generation of mutant viruses. E protein mutants were introduced into the full- 
length infectious clone for MHV A- 59. The full- length cDNA clone for wild 
type (WT) and mutant viruses were assembled, in- vitro transcribed and 
electroporated into BHK- MHVR cells as described previously.The cells were 
overlaid with L2 cells to enhance virus production. Cells were monitored for 
cytopathic effects (CPE) 24- 36 hours post electroporation. An aliquot of the 
supernatant was taken and used to infect fresh L2 cells. The electroporated cells 
were harvested to extract total RNA using RNaqueous- 4PCR extraction kit 
(Ambion). The extracted RNA was DNase treated to remove any extraneous DNA 
and used as a template for reverse transcription (RT) using an oligo dT primer 
(Superscript, Invitrogen). The RT product was used as a template to amplify the E 
and M genes with the forward and reverse primers (EM+/-) for 30 cycles using 
the SuperTaq plus kit (Ambion). The PCR product was purified using Qiagen’s 
minielute columns and directly sequenced. Supernatant from the electroporated 
cells was used to purify viruses and passaged five times on 17Cl1 mouse cells. 
RNA was extracted from passages 1 and 5, reverse transcribed and amplified for 
the E and M genes. This was further sequenced to confirm the presence and 
stability of the introduced mutations. The mutant viruses also carried a silent 
change in the codon for alanine at residue 22. This was also confirmed from 
sequencing information. 
Growth Kinetics. Growth kinetics analysis was performed in duplicate for all 
WT and mutant viruses by infecting 17Cl1 cells at a multiplicity of infection 
(MOI) of 0.01. Supernatant was harvested at indicated times post infection. Titers 
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were determined by standard plaque assay on L2 cells. At 72 hours post infection, 
the agarose/ medium overlay was removed and the cells were fixed and stained 
with crystal violet in ethanol. Plaques were counted and virus titer at each time 
point was determined. All data was collected in duplicate. 
Generation of pCAGGS constructs. pScript E containing WT and mutant E 
proteins were used as a template to subclone WT and mutant E proteins into 
pCAGGS expression vector . The E gene was amplified using the forward (GGG 
CCA AAT TCG AAA GAA ATG) and reverse (GCA TCG ATT TAG ATA TCA 
TCC ACC TCT AAT AG) primers to introduce EcoRI and ClaI restriction 
enzyme sites flanking the E gene for subcloning. The product was resolved on an 
agarose gel and the 250 base pair product was extracted using Qiaquick gel 
extraction kit (Qiagen). The eluted product was co- digested with EcoRI and ClaI 
(New England Biolabs) and purified by Qiaquick nucleotide removal kit (Qiagen) 
and ligated into alkaline phosphatase treated pCAGGS vector digested with 
EcoRI , ClaI. Ligation was confirmed by restriction digestion and direct 
sequencing of the E gene.  pCAGGS vectors expressing WT M was constructed 
as previously described.  
Negative staining of virions. Ten T- 150 cell culture flasks of 17cl1 mouse cells 
were infected at an MOI of 0.01 with WT and mutant viruses. Viruses were 
harvested at different times post infection ranging from 22- 40 hours post 
infection. Supernatant was clarified at 7500 X g for 10 minutes. Viruses were 
concentrated at 90,000 X g for 2 hours onto a 60% sucrose cushion in TMEN 
(50mM Tris –maleate pH 6.0, 0.1 M NaCl, 1mN EDTA). The concentrated 
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sample was isopycnically centrifuged on an 30 ml 20- 60 % (wt/wt) sucrose 
gradient in TMEN for 4.5 hours at 90,000 X g. Upon centrifugation, fractions 
were collected and the density of fractions were determined using a refractometer. 
Fractions having a density of 1.18- 1.20 g/cm3 were pooled together and diluted to 
get a final sucrose concentration of 30%. The viruses were pelleted at 90,000X g 
for 2.5 hours. The pellet was resuspended in 300μl TMEN. Five microliters of 
each virus was adsorbed onto a formvar coated 400 mesh EM grid in a humid 
chamber. Grids were stained by placing on a 10μl drop of 0.5% ammonium 
molybdate (pH 6.5) for 30 seconds. Excess liquid was drained from the side of the 
grid with a filter paper and air dried for five minutes. Samples were examined in a 
transmission electron microscope at 66,000 X magnification.   
VLP analysis. 293 T cells were transfected with 1µg of pCAGGS vector 
expressing WT or mutant E proteins singly or in combination with 1µg pCAGGS 
vector expressing WT M protein using TransLT- 293 transfection reagent (Mirus) 
as per manufacturer’s recommendation. The total amount of DNA in each 
transfection was normalized to 2µg using pCAGGS empty vector. At 24 hours 
post transfection, the supernatant was clarified at 14000 X g for 10 minutes at 40 
C. VLPs was pelleted by centrifuging the clarified media at 40C through a 30 % 
sucrose cushion in a Beckman SW55Ti at 30,000 rpm for 3 hours. Pellets were 
directly resuspended in Laemlli sample buffer.  The cells were washed gently 
with phosphate- buffered saline (PBS) and lysed on ice in a buffer containing 100 
mM Tris, 100 mM NaCl, 0.5% Triton X-100, and 1 mM phenylmethylsulfonyl 
fluoride (PMSF).  Nuclei were pelleted and the supernatant was stored at – 800C 
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for Western blot analysis. Intracellular and extracellular samples were resolved by 
SDS- PAGE and proteins were transferred onto polyvinylidene difluoride 
membranes. Extracellular fraction was probed for M using goat anti M AO3 
antibody (kindly provided by Kathryn Holmes, University of Colorado Health 
Sciences) and E using rabbit anti E 9410 antibody. The intracellular fraction was 
probed for M, E and actin (mouse anti β actin antibody ab 6276 -Abcam) 
E protein stability. 293 T cells were transfected with 1µg pCAGGS vectors 
expressing WT or mutant E proteins. At 12 hours post transfection, one set of 
dishes was lysed, representing “0” or starting time point. Protein translation 
inhibitor, cycloheximide (Sigma) was added to other dishes at 50 µg/ ml. One set 
of dishes was lysed at 2, 4 and 6 hours after addition of cycloheximide.  Samples 
were analyzed by SDS- PAGE and Western Blotting. Rabbit anti- MHV E 9410 
was used to detect the levels of E proteins.  Mouse anti- ß actin antibody 6276 
(Abcam) was used to detect intracellular actin as a loading control. Bands on the 
X- ray films were quantified using Image J (Rasband WS 1997-2011; Abramoff, 
M.D., Magalhaes, P.J. and Ram, S.J 2004). Half- life of WT and mutant E 
proteins were calculated assuming first- order kinetics for the degradation of E 
proteins. 
Virus release. Mouse 17cl1 cells were infected with WT or mutant viruses at an 
MOI of 0.01. At 16 h p.i. , supernatant and cells were harvested separately.  The 
supernatant containing extracellular virus was clarified to remove cell debris. An 
equal volume of medium was added to the cell monolayer and subjected to three 
freeze- thaw cycles to release intracellular virus. Both fractions were titrated on 
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L2 cells to determine virus titer. The percentage of virus release was determined 
as the percentage of extracellular virus titer over the sum of intra and extracellular 
virus titers.  
Peptide synthesis: Two peptides were synthesized for the analysis of their 
interaction with different lipids: TLVLSPSIYLYDRSK (WT) and 
TLVLSASIALYDRSK (5476). Peptides were synthesized either at the School of 
Life Sciences in house facility or ordered from Genscript (New Jersey, USA). The 
peptides were N terminally acetylated and C terminally amidated and purified by 
FPLC when necessary. 
Peptide: lipid interaction analysis: Peptides were dissolved in 
chloroform/methanol at indicated molarity. The solvent was then evaporated 
under a stream of nitrogen with constant rotation of a test tube so as to deposit a 
uniform film over the bottom third of the tube. Last traces of solvent were 
removed by placing the tube under high vacuum for at least three hours. The lipid 
film was then hydrated with 20 mM PIPES, 1 mM EDTA, 150 mM NaCl with 
0.002% NaN3, pH 7.40 and suspended by intermittent vortexing and heating to 
50°C over a period of 2 minutes under argon. Peptides and lipids were mixed at 
indicated mole fractions. Cholesterol was added for CRAC identification at 
indicated molarity.  Differential scanning calorimetry was performed in samples 
with heating and cooling cycles. Measurements were made using a Nano 
Differential Scanning Calorimeter (Calorimetry Sciences Corporation, Lindon, 
UT). Each sample was scanned with 2–3 cycles of heating and cooling between 0 
and 60 °C. The scan rate was 2°C/min and there was a delay of 5 minutes between 
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sequential scans in a series to allow for thermal equilibration. DSC curves were 
analyzed by using the fitting program, DA-2, provided by Microcal Inc. 
(Northampton, MA) and plotted with Origin, version 5.0.The melting and phase 
transition temperatures were measured based on heat absorbance of the sample 
during the temperature scans. This analysis was performed by personnel in Dr. 
Richard M. Epand’s laboratory at McMaster University, Hamilton, Canada.  
 
         
 
 
 
 
 
 
 
 
 
 
 
 
  86 
RESULTS 
 
Alanine substitution mutants have reduced virus output. To analyze the 
significance of the conserved proline and tyrosine residues alanine substitutions 
were introduced into the MHV-A59 genome by reverse genetics. Proline residues 
at positions 54 and 76 and tyrosine residue at position 57 were replaced with 
alanine singly and in combination (Fig. 14). For each construction, a WT control 
virus was assembled in parallel. Infectious viral particles were recovered for all 
constructs (Fig. 14). RNA was extracted from the electroporated cells and the E, 
M and N genes was sequenced. Sequence analysis revealed that all introduced 
mutations were maintained and no compensatory changes were identified in any 
of the genes sequenced.  
Even though viruses were recovered for all introduced mutations, plaque 
size revealed that P54A, Y57A and P76A produced plaques somewhat smaller than 
WT and P54AY57 A and P54AP76A produced very tiny plaques (Fig. 14). This 
indicated that while the proline residues are not absolutely essential for virus 
production, replacement of the residues was compromising virus output in an 
unknown mechanism.  Individual plaques were isolated for each virus and 
passaged 5 times. At the end of the 5th  passage, RNA was extracted from infected 
cells and E, M and N genes were sequenced. Sequencing confirmed that the 
introduced mutations were stable, with no secondary changes in E, M and N 
genes.  
To further understand the growth properties of the mutant viruses, 17Cl1 
mouse cells were infected at a low MOI of 0.01.  
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Figure 14: Characterization of mutant viruses 
Recovered viruses were plaqued on L2 cells . Cells were stained with crystal 
violet 3 days after infection (top). 17cl1 mouse cells were infected at an MOI of 
0.01. Samples were collected at indicated times post infection and virus titer was 
determined using a standard plaque assay.  
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Samples were collected over a period of 20 hours and analyzed by plaque 
assay on L2 mouse cells. The growth kinetics suggested that, while all mutations 
affect virus production, mutations in the P54 and Y57 residues had ~2 log reduction 
in virus output and the P76 residue has less than 1 log reduction in virus output. 
The double mutants P54AP76A and P54AY57A were found to be highly crippled 
with ~ 3 log reduction in virus output. At 20 hours post infection, the growth 
kinetics data indicates that the single mutants may be able to achieve WT- like 
titers. However, we think that this may be due to the fact that they may have more 
uninfected cells than in the WT infection, thereby, allowing virus production for a 
longer time, as compared to WT, before plateauing.  
Mutations do not affect virus morphology. Previous work on residues in the tail 
of the E protein was identified to be critical for virus morphology. Since these 
residues were in the same region as previously identified residues, virus 
morphology of each of the mutations was studied. None of the mutations were 
found to have an effect on virus morphology. All viruses were found to have a 
WT like morphology (Fig.15).  
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Figure 15: Mutations have no effect on virion morphology 
Top panel indicates mutant viruses recovered by Samsonoff et.al., (1998). Mutant 
viruses were elongated and found to be thermo labile.  (Used with permission 
from Journal of Virology). 
Bottom panel shows WT and mutant viruses generated and purified and stained 
with 0.5% ammonium molybdate. All viruses were found to have WT like 
morphology.  
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Proline at position 54 is more sensitive to changes. When expressed by itself, 
WT E localizes to the ERGIC- Golgi region and WT M localizes to the Golgi. 
However, when WT E and M are co-expressed, E localizes with M at the site of 
assembly in the ERGIC. To determine if the introduced mutations affect 
localization of the E protein BHK- 21 cells were transfected with pCAGGS 
vectors expressing WT and mutant E proteins alone and also in combination with 
a pCAGGS vector expressing the M protein. Immunofluorescence analysis of 
cells revealed that mutant E proteins appear to have a WT E like localization 
when expressed alone and also when co- expressed with M. Similar co- 
localization was seen upon infection (Data not shown).  Previous studies have 
established that co- expression of E and M are the minimal requirements for 
envelope formation for MHV. To determine if the introduced mutations affect 
envelope formation, pCAGGS vectors expressing WT and mutant E proteins were 
transfected singly and in combination with pCAGGS vector expressing MHV M 
protein into HEK 293 cells. At 23 hours post transfection, cells were lysed and the 
media from the transfected cells were harvested and pelleted through a 30% 
sucrose cushion. The intracellular and extracellular fractions were analyzed by 
Western blotting for the E and M proteins. The presence of M in the pellet 
indicates envelope formation, since the protein is not transported out of the Golgi 
when expressed alone. All mutant E proteins except 5457 and 5476 were found to 
be competent for envelope formation since M was present in VLPs pelleted from 
the supernatant. When the E protein is over- expressed, it can be released as 
vesicles. Such vesicles were seen when WT and mutant E proteins were able to 
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generate such vesicles when expressed by singly or in combination with MHV M. 
Taken together these results suggest that single replacement of these residues does 
not alter the localization of the E protein. The loss of VLP formation by 5457 and 
5476 mutants strongly indicate that these residues are required for interaction with 
M. (Data not shown) 
Virus release is affected. In order to further determine the stage in the virus life 
cycle affected by these mutations in the E protein, the percentage of virus released 
upon infection was determined. Media from infected cells were plaqued for the 
extracellular virus titer and infected cells were frozen and thawed to release the 
intracellular virus. Virus release was calculated as a percentage of extracellular 
virus titer relative to total virus produced .WT virus consistently released 90 % of 
the virus produced, whereas all mutant viruses released around 50 % of virus 
produced. This clearly indicated that mutations in these residues affected virus 
release. While P76A significantly affects only virus release, P54A and Y57A affect 
virus production as well as release (Fig. 16- top panel). 
 Mutations affect protein stability. 293 cells were transfected with pCAGGS 
vectors expressing WT and mutant E proteins. At 12 hours post transfection, 
cycloheximide was added to prevent further translation. At 0, 2, 4 and 6 hours 
post addition of cycloheximide, cells were lysed and analyzed for the levels of E 
using Western Blotting. The bands were quantified and the half-life of WT and 
mutant E proteins were calculated using first order kinetics. WT E had a half-life 
of 90 min. All mutants with a proline- to – alanine change had a reduction in their 
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half-lives. P54AP76A was severely unstable and had a half-life of only 10 minutes. 
Interestingly, Y57A was as stable as WT E at 91 minutes (Fig. 16 – bottom panel).  
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 Figure 16: Mutations affect virus release and protein stability 
  17cl1 mouse cells were infected at an MOI of 0.01. At 16 hpi, the extracellular 
(supernatant) and intracellular (cell- associated) viruses were titered using a 
standard plaque assay. Bar graphs indicate virus titers. Percentage of virus release 
was calculated as a percentage of extracellular virus over total virus produced.  
Virus release percentages are indicated above the bar graphs for each mutant. 
293 cells were transfected with plasmids expressing WT and mutant E proteins. 
At 12 hours post transfection, cycloheximide was added to prevent protein 
translation. At indicated times post addition of cycloheximide, cells were lysed 
and analyzed for E protein by Western blotting. The levels of E were quantified 
using Image J and were fit to a first order kinetics. The half-life of WT and E 
mutants were calculated from the first order kinetics reaction. 
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E protein does not contain a functional CRAC motif and may induce 
membrane curvature. Peptides encompassing residues 50- 62 of the E protein 
was synthesized. The WT peptide ELVLSPSIPLYDRSK and 5457 mutant 
peptide ELVLSASIALYDRSK were used to analyze their interaction with 
cholesterol and various lipids using differential scanning nanocalorimetry. 
Initially, differentially scanning calorimetry was performed using the peptides 
with the lipid SOPC in the presence and absence of cholesterol. The melting 
temperature (Tm ) of SOPC with 40% cholesterol in the absence of WT or 5457 
was 40 C. The melting temperature of SOPC with 40% cholesterol in the presence 
of WT or 5457 peptides at 15 mole fraction was also 40C. This suggested that 
both the peptides did not interact with cholesterol. However, the enthalpy of 
transition (ΔH) was transition was much lower for SOPC with 40% cholesterol in 
the presence of both WT and 5457 peptides. This suggested that both WT and 
5457 peptides were able to interact with an SOPC lipid bilayer. They were able to 
dramatically reduce the enthalpy of phase transition in a concentration dependent 
manner, suggesting that they were able to get incorporated into the lipid. WT 
peptide was able to reduce the phase transition temperature and the enthalpy of 
transition of POPS as a function of mole fraction, but 5457 peptide had no effect 
on either. Both WT and 5457 mutant peptides had a concentration dependent 
interaction with POPE. WT peptide had an effect on the inverted hexagonal phase 
transition temperature of POPE. This indicates that the WT peptide may be 
promoting a negative curvature of the lipid bilayer by destabilizing the bilayer. 
No such effect was seen upon the addition of the 5457 mutant peptide (Fig. 17). 
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Figure 17: WT peptide interacts with lipids and is not a functional CRAC 
motif 
The top three graphs describe the total enthalpy changes during 
differential scanning calorimetry. The melting temperature (Tm) of the lipid SOPC 
with 40% cholesterol is identical in the presence and absence of lipids. The 
bottom four graphs show the interaction of WT and 5457 peptides with various 
lipids. 
WT (dark grey) and mutant (light grey) peptides were mixed in increasing mole 
fractions with indicated lipids and differential scanning calorimetry was 
performed. Bar graphs indicate the melting temperatures (Tm ) or hexagonal phase 
transition temperature (TH ) from the heating cycles.  
Results obtained in collaboration with Richard Epand, McMaster University 
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DISCUSSION 
Assembly of coronaviruses at intracellular membranes is a significant area 
of interest. This mechanism is not clearly understood. The envelope protein, 
although found in low abundance in the virion, plays a pivotal role in viral 
assembly, trafficking and release (Kuo and Masters 2003; Boscarino et al. 2008; 
Ye and Hogue 2007; Ortego et al. 2007). Deletion of the E gene from various 
coronavirus genomes results in severely crippled or lethal phenotype (Kuo and 
Masters 2003; Ortego et al. 2007). In MHV, deletion of the E gene from the virus 
genome did not affect virus replication, but severely decreased virion production 
(Kuo and Masters 2003). The transmembrane domain of the MHV E protein has 
been shown to have an ion channel activity in context of the virus and in planar 
lipid bilayers in vitro (Wilson, Gage, and Ewart 2006; Madan et al. 2005). Our 
previous work showed that the E transmembrane domain is important for the 
protein to function efficiently during virus assembly and release (Ye and Hogue 
2007). Others and we have also shown that the conserved cysteine residues 
following the TMD are necessary for assembly and virus (Boscarino et al. 2008; 
Lopez et al. 2008).  An earlier study showed that charged residues at the end of 
the E tail are important for virus production and virion morphology (Fischer et al. 
1998).  This paper investigates the role of the conserved prolines and tyrosine in 
the tail of the E protein. Our results indicate that these residues, and the overall 
structure of the protein as conferred by these residues are required for efficient 
virus assembly, trafficking and release. However, these residues are not 
  99 
absolutely essential for localization and interaction with the M protein for 
envelope formation. 
The presence of two highly conserved proline residues in the tail of the E 
protein suggested that these residues may have an evolutionarily conserved 
function. To answer this question, site-directed mutagenesis was used to construct 
single and double proline to alanine substitution mutant viruses using the 
previously described reverse genetics system. Viruses were recovered for both 
single and double proline to alanine mutants. This clearly indicated that these 
proline residues were not required for virus assembly. However, based on the 
effect of the proline to alanine substitutions, it is clear that these residues play a 
significant role in virus production. 
Upon further analysis of the recovered mutants, they were found to be 
stable, but viruses containing the mutations were far less robust than the wild- 
type virus. Growth kinetics analysis of the viruses showed that the proline to 
alanine double mutant was extremely crippled, whilst the single mutants were 
affected to different extents.  The proline- 54 was found to be more sensitive to 
changes than proline 76, which may reflect the fact that proline 54 is conserved 
strictly among all coronavirus E proteins.  This strongly suggests that these 
mutations had an effect on virus assembly. 
Co-localization analysis and virus-like particle (VLP) formation along 
with the M protein conclusively showed that these mutants interacted like WT E 
to localize correctly and form the envelope. The introduced mutations did not 
inhibit envelope formation and correct localization of the E protein.  It is 
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interesting to note that envelope formation is not inhibited when the mutant E 
proteins and M are expressed in cells, whereas virus assembly is affected 
significantly for some of the viruses. We attribute this to the fact that the high 
amount of the mutant E protein during transfection most likely overshadows the 
effect of the mutation on envelope formation. It should be noted that we have not 
quantified the VLP output. Thus, additional work is necessary to address this.  
Previous data for MHV E showed that mutations in the tail affected the 
thermostability of the virus. The overall stability of the mutant E proteins was 
affected. The proline to alanine double mutant was found of have a half-life 10 
times less than the WT E protein, as determined following transfection. The 
mutant of Y57A was found to be as stable as WT E but did not achieve WT- like 
growth characteristics. Thus, this would suggest that the structure is possibly 
altered. 
Previous work for TGEV has shown that the deletion of the E protein 
results in arrest of virion trafficking (Ortego et al. 2007). Affecting the 
hydrophobic domain of the MHV E protein also results in reduction in virus 
release (Ye and Hogue 2007). In case of the proline to alanine mutants, all the 
mutants were affected in virus release. This can be seen in both the intracellular 
and extracellular titers and the virus release data. It is interesting to note that when 
heterologous E proteins were substituted for MHV E, they were tolerated to a 
large extent. Only substitution of TGEV E for MHV E resulted in various gain of 
function mutants. One of these mutations was P57A, which is homologous to P54 in 
MHV E (Kuo, Hurst, and Masters 2007). The gain of function mutant was still 
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unable to achieve wild- type MHV characteristics. This suggests that the overall 
structure of the tail of E protein is crucial for interaction with other viral proteins 
and host proteins. 
Given the highly hydrophobic nature of the E protein and challenges 
involved in large-scale production of the protein have prevented obtaining a 
crystal structure of E so far. In silico analysis of all the mutant E proteins using 
multiple prediction softwares and a consensus structure of E was obtained (npsa-
pbil.ibcp.fr/). This predicted structure was used as a basis for analyzing the effect 
of the mutations on the structure of the E protein (Fig. 18). The tail of the E 
protein is predicted to have a coil-strand-coil-strand-helix conformation and P54A 
repositions the first strand to a coil conformation. Y57A is not predicted to induce 
any structural change in the protein. P76A is predicted to extend the last helix in 
the tail. P54AY57A is predicted to disrupt the tail structure to a coil- helix- strand- 
helix conformation. P54AP76A changes the conformation to coil-strand-strand-coil 
conformation and extends the tail helix (Fig. 18). These predicted change would 
explain the difference in growth properties of these mutant viruses compared to 
WT. While previous data indicates that the mutant E proteins may be partially 
functional, the stability data and structure prediction data suggests that the 
structure of the E protein may be affected.  
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Figure 18: Secondary structure prediction of E proteins. 
Amino acid sequence of WT MHV E protein is shown. Multiple secondary 
structure prediction softwares were used to generate a consensus structure of the 
WT and mutant proteins. (npsa-pbil.ibcp.fr/).  The two underlined areas indicate 
the predicted CRAC sequences. Proline to alanine mutations cause a coil- to – 
strand change or a coil – to- helix change. Tyrosine to alanine substitution causes 
a strand to helix change. 
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 Recent work on the tail of the SARS envelope protein suggests that the 
proline corresponding to P54 in MHV E and a motif encompassing the Y57 may 
play a role in the Golgi localization of the E protein (Cohen, Lin, and Machamer 
2011). However, this was tested using the tail of the SARS E protein linked to the 
amino and hydrophobic domains of VSV-G and the construct was tested for 
surface trafficking. Recently, the localization of SARS E has been defined to the 
ERGIC/ Golgi region and does not traffic to the cell surface (Nieto-Torres et al. 
2011, Venkatagopalan et.al. Submitted 2012). We have clearly shown that MHV 
E does not traffic to the cell surface. The mutants generated in this paper were 
found to localize in the perinuclear region and the mutations had not effect on the 
protein localization (data not shown).  The severely crippled mutants- 54-57 E 
and 54-76 E did not traffic to the cell surface. It is possible that the mutation in 
the motif affects the secondary structure of the region, thereby affecting E-E, E-M 
and E- host protein interactions. The highly charged tail of the E protein is likely 
positioned away from the lipid membrane and interacts with viral and host 
proteins. 
 The motif comprising residues 50-62 of MHV E contains of a putative 
cholesterol recognition amino acid consensus (CRAC) sequence (R. F. Epand, 
Sayer, and Epand 2005; R. M. Epand 2006). Such functional CRAC sequences 
have been identified in HIV gp41 and influenza M2 proteins (Greenwood et al. 
2008; Stewart et al. 2010). The CRAC motif in the HIV gp41 is important for 
virus entry and membrane fusion. The CRAC motif in the influenza M2 protein 
has been suggested to play a role in virion pinching-off during virus budding 
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(McCown and Pekosz 2006). It was hypothesized that the CRAC motif in the tail 
of the E protein may be playing a role in membrane budding. However, upon 
testing the WT and 54-57 mutant peptide did not reveal any cholesterol binding 
properties (data not shown). It was also observed that the peptides themselves 
interacted differently with the lipids. Upon further analysis, it was found that the 
WT and 5457 peptides interacted differently with different lipids. The observation 
that the WT peptide could interact well with POPE and could reduce the inverted 
hexagonal phase transition temperature was a very surprising observation. The 
inverted hexagonal phase transition occurs when lipids bilayers are destabilized 
and undergo a negative curvature. This is a very significant observation because 
this is the first time the direct interaction of the WT E motif with lipids have been 
shown and the ability of the WT peptide may induce a negative curvature in the 
membrane. Budding of coronaviruses takes place into the lumen of the ERGIC 
(Bost, Prentice, and Denison 2001).The E protein localizes in the ERGIC/Golgi 
region. As virions bud into the lumen of the ERGIC, EM images show that the 
membranes undergo a negative curvature (Fig.19). The orientation of the E 
protein is such that the tail of the E protein is oriented in the cytoplasm. 
Therefore, it is mechanistically feasible for the tail of the E protein to drive 
forward this change in the membrane curvature. The E protein may be functioning 
as a direct or indirect scaffold to aid negative membrane curvature, thereby 
initiating budding or aid in scission of fully assembled virions (Fig.19). Future 
experiments will examine the effect of full length MHV E on lipid vesicles and 
membrane curvature. 
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Figure 19: Mechanism of action of the E protein 
   The tail of the E protein may induce negative curvature in membranes. 
Schematic on the left shows the various membrane modifications that occur for 
the formation of a vesicle or a bud. Negative curvature is essential to either 
initiate budding or to complete bud pinch off. The E protein could be playing a 
role in initiating budding or virion pinching off or both. The E protein may 
function as a direct scaffold by directly interacting with the membranes or by 
interacting with other viral and host proteins. 
Membrane curvature and mechanisms of dynamic cell membrane remodelling 
Harvey T. McMahon & Jennifer L. Gallop. Nature 2005. 
Adapted with permission from Nature publishing. 
 
 
!"
#"
$"
%&"
  107 
Further studies will be performed to characterize the effect of these mutants on 
the ion channel activity of the E protein in artificial lipid bilayers. SARS E has 
been predicted to form pentameric oligomers in artificial lipid bilayers (Torres et 
al. 2006). 
We will further look into analyzing the effect of these mutations on the 
oligomerization of E.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  108 
ACKNOWLEDGEMENTS 
Dr. Sasha Daskalova contributed to recognition and many subsequent 
discusions of the putative CRAC motifs in coronavirus E proteins. She selected 
and worked with the ASU Proteomics and Protein Chemistry Core Facility on 
synthesis and purification of the wild-type and mutant peptides. Dr. Zbigneiw 
Cichacz developed the protocol and subsequently purified the mutant peptide. The 
analysis of the putative CRAC motif and differential scanning calorimetry 
experiments were performed by personnel in Dr. Richard Epand’s laboratory at 
McMaster University, Hamilton, Canada.
  109 
Chapter 4 
SUMMARIZING DISCUSSION 
The localization, dynamics and function of the coronavirus envelope (E) 
protein have been examined in this study. Multiple studies have examined the 
localization of various coronavirus E proteins using various expression systems. 
The results of all these studies have been inconsistent. This study examines the 
localization of the E protein in a relevant context of virus infection and optimal 
expression levels. The E protein localizes at the membranes of ERGIC and Golgi 
during infection and upon expression. This study also uses multiple approaches to 
determine that the E protein does not traffic to the cell surface, suggesting that the 
function of E is at the site of assembly in the ERGIC/ Golgi region. The 
orientation of the E protein has also been confirmed. The MHV E protein has a 
single pass transmembrane domain, with the amino terminus exposed to the 
lumen or outside the virion and the carboxy tail in the cytoplasm or inside the 
virion. This is the first study to successfully generate a functionally tagged MHV 
E protein. A small tetracysteine tag was appended to the carboxy end of the E 
protein (E-Lumio) and examined for localization and virion production. The E- 
Lumio protein localized like WT E and was functional in generating VLPs and 
recombinant viruses. The advantage of the tetracysteine tag is that it allowed for 
the visualization of E-Lumio in cells using a fluorescein/resorufin biarsenical 
derivative. This is the first study to follow live imaging of E using MHV E- 
Lumio recombinant virus. This also confirmed that the E protein did not traffic 
out to the cell surface. The dynamics of the E protein was studied using 
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flourescence recovery after photobleaching (FRAP) analysis. This data revealed 
that the E protein was mobile at the sight of assembly and had a wide range of 
mobility. This is the first study to establish and utilize correlative light electron 
microscopy (CLEM) to study any aspect of coronavirus infection. This 
challenging technique further confirmed that the E protein localized to the 
membranes of the ERGIC/ Golgi. This part of the study clearly demonstrated that 
the E protein localizes and functions at the site of assembly. 
Sequence alignment of coronavirus E proteins revealed the presence of 
conserved prolines at positions 54 and 76 and tyrosine at position 57 for MHV. 
These residues were targeted for site directed mutagenesis and recombinant 
viruses were generated. While none of the residues were essential for the function 
of E, changes around residues 54 and 57 showed that they were more critical to 
the functions of E. Apart from affecting protein stability, all the changes affected 
virus release. Bioinformatics analysis suggested the presence of a cholesterol 
recognition amino acid consensus (CRAC) sequence in the tail of the E protein 
encompassing residues 54 and 57. WT and mutant synthetic peptides were used to 
determine any cholesterol interaction using differential scanning calorimetry. 
While these peptides did not interact with cholesterol, preliminary analysis 
suggested that the WT peptide preferentially interacted with lipids compared to 
mutant peptides. The WT peptide was able to reduce the melting temperature of 
the lipid bilayers in a concentration dependent manner. Of more significance, was 
the ability of the WT peptide to reduce the hexagonal phase transition temperature 
of the lipid phosphatidyl-oleyl phosphatidyl ethanol amine (POPE). The 
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hexagonal phase transition is responsible for a lipid bilayer to undergo a negative 
curvature. This is the first study to suggest that the E protein may be playing a 
mechanical role at the site of assembly by possibly inducing a local negative 
membrane curvature. This opens up many possibilities to the functions of E at the 
site of assembly.  
Previous data has shown that the hydrophobic domain of E is sufficient for 
membrane insertion and pore formation(Wilson, Gage, and Ewart 2006; Torres et 
al. 2007). It is possible that the transmembrane domain, the palmitoylated 
cysteines and the tail may interact with the lipid bilayer differently to initiate a 
negative change in membrane curvature. Negative curvature plays an important 
role in two spatio-temporal points of any budding. The leading edge of the bud 
has a positive curvature, and the lagging edge of the bud has a negative curvature. 
When any budding occurs into the cytoplasm, cellular membrane curvature 
sensing protein and stabilizing proteins drive this reaction (Fig.19). The factors 
needed to initiate and stabilize budding into the lumen are unknown. It is possible 
that E plays such a role by either functioning as a direct scaffold or interactions 
mediated through host proteins. One of the important interactions to induce any 
structural change in the cell is mediated by cytoskeletal interactions.  Mass 
spectrometry analysis shows that SARS E interacts with dynein, a cytoskeletal 
motor (Alvarez et al. 2010). Moreover, E and M proteins function together to 
release VLPs. The M protein has been shown to interact with actin. It is possible 
that E-M-cytoskeleton involvement drives budding. The M protein forms the 
lattice of the viral envelope (Bárcena et al. 2009). The E and M proteins are the 
  112 
minimal requirements for MHV envelope formation. M protein has been 
described to be in two conformations M long and Mshort and thought to exist in 
equilibirium (Neuman et al. 2011). The Mlong conformation has been associated 
high curvature membranes and efficient virus budding, whereas the Mshort 
conformation has been associated with low membrane curvature and in inefficient 
budding (Neuman et al. 2011). The structural differences between these 
conformations are unknown, but recent work by Arndt et.al, as suggested that this 
change may be mediated by residues in the tail of the M protein (unpublished data 
from Hogue lab). Further, the mechanisms responsible for the conversion of M long 
to M short are unknown. It is possible that the membrane bending ability of the E 
protein may stabilize M in the Mlong conformation. The torsional stress by a highly 
curved membrane may be responsible for the conversion and /or stability of the M 
long conformation (Fig. 20). Further, at the completion of any budding, the neck 
region undergoes high degree of negative curvature before the vesicle pinches off.  
Normally, the host ESCRT pathway plays a role in this process, but there are no 
known late domains in any of the coronavirus structural proteins. Moreover, 
previous studies show that blocking the ESCRT pathway has minimal impact on 
virus assembly and release (Raaben et al. 2010 and unpublished data from Hogue 
lab). Recent data has shown that the influenza M2 protein plays a role in virion 
pinching off in an ESCRT independent pathway. While E protein is expressed 
well in infected cells, very few molecules are incorporated in virions. The E 
protein may play a similar role at the site of assembly and E incorporation into the 
virions may be incidental.  
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Figure 20: Mechanistic role of E in driving virus assembly 
The E protein may play a role in the conversion and stabilization of Mshort 
to Mlong. The E protein may induce a high degree of membrane curvature to drive 
efficient budding (panel- left). The M protein forms the lattice of the virus lattice. 
While the M protein is the main protein in maintaining the structure of the viral 
envelope, the E protein and the nucleocapsid play a role in driving virus assembly 
(panel- right).  
 
Used with persmission from Neuman 2011, Barcena 2009, Verma 2007, Arndt 
2010 unpublished 
!  !"#"$"!"%&'("
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The E protein has a cation channel activity (Madan et al. 2005; Wilson, 
Gage, and Ewart 2006). NMR data shows that SARS E organizes pentameric 
bundle to form the ion channel pore in artificial lipid bilayers(Torres et al. 2006). 
It is possible that the membrane bending ability of the E protein may enhance or 
direct the formation of the ion channel. The ion channel activity of E may also 
change a luminal ionic concentration, which may effect the conversion of M short to 
Mlong form. The membrane bending ability of the E protein may also play a role in 
gating the ion channel activity of E. Peptides in various viral proteins have been 
identified that have a membrane bending ability and play a functional role in 
membrane fusion (Greenwood et al. 2008). Most of these are found in surface 
glycoproteins of various viruses. It is possible that E plays a similar role at the site 
of assembly.  
The E protein has been suggested to be a virulence factor (DeDiego et al. 
2008). This is likely due to an indirect effect of E, since the protein does not 
traffic out to the cell surface and plays no unknown role in virus entry. However, 
the E protein may cause local membrane modifications that can be sensed by 
cellular membrane curvature sensing molecules like TLR 4 and TLR 7 (Maier et 
al. 2010). Signaling through these molecules may activate pathways in the cell 
that may increase the pathogenicity of virus infection. 
In the future, the mechanistic role of E can be analyzed using an artificial 
liposome based assay to directly study the effect of full length E on membrane 
curvature. High levels of expression of the E protein has been shown to be 
associated with membranes of very high curvature. While the E protein may be 
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making small local changes at earlier times upon infection, the accumulation of E 
at late times post infection may result in gross membrane modification 
(Raamsman et al. 2000; Ulasli et al. 2010). At the site of virus budding, there is a 
higher concentration of electron dense stain, likely caused by osmium tetroxide. 
Osmium tetroxide specifically targets unsaturated bonds in the side chains of 
lipids. This suggests that there is a local lipid rearrangement to allow virus 
budding (Lee and Ahlquist 2003). A comparative mass spectrometric analysis of 
the WT and mutant viruses will reveal any differences in the lipid content of the 
virions, which may be attributed to the differences in the E protein. The mutant 
proteins were not tested for their palmitoylation status. It is possible that the 
mutations may have prevented the E protein from being palmitoylated. Proline 
residues at the end of transmembrane domains play a role in ion channel gating 
(Choe and Grabe 2009). The predicted structural changes at the 54-57 region may 
have affected the gating of the MHV E ion channel. SARS E has been shown to 
be ubiquitinated, while the functional significance of this is not known, it is 
unknown whether MHV E has been ubiquitinated (Alvarez et al. 2010). 
Bioinformatics analysis of the E protein reveals the presence of a putative clathrin 
binding motif at the tail of E protein. While clathrin has not been implicated in 
coronavirus assembly, it is possible that the tail of the E protein may be 
interacting with multiple host proteins. Mass spectrometric analysis using the 
Strep- tagged E could be used to identify the host proteins that E may interact 
with.  
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APPENDIX A  
OPTIMIZATION OF THE USE OF THE TETRA-CYSTEINE TAGGED E FOR 
USE IN CORRELATIVE LIGHT ELECTRON MICROSCOPY (CLEM) AND 
LIVE CELL IMAGING 
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INTRODUCTION 
 Correlative Light Electron Microscopy (CLEM) is a complex technique in 
microscopy that combines light and electron microscopy (Current protocols 
CLEM). Immunofluorescence provides invaluable information regarding the 
location of proteins in the cells, but a single fluorescing single spot may represent 
protein aggregates, trafficking vesicles or an entire organelle. Identification of the 
location of a protein in a cell requires ultrastructural information. This 
information can be gathered by performing thin section transmission electron 
microscopy on the same cells from where live-cell IF data has been collected. 
This allows one to observe the location of a protein and in the same cell determine 
at the ultrastructures that the protein is associated with.  This method is called 
correlative light electron microscopy (CLEM). CLEM has successfully been used 
by other researchers to study the localization of GFP-tagged cellular proteins by 
live cell imaging, followed by thin section TEM analysis in the same cell.  
Lumio TM  (Invitrogen) is a short 6 amino acid tetracysteine peptide (Cys-
Cys-Xaa-Xaa-Cys-Cys) that can be appended to a protein without generally 
disrupting its structure or function. Lumio TM labeling reagents are based on 
biarsenical labeling reagents bind to the tetracysteine tag when added to cells and 
under appropriate wavelength fluoresces with high specificity (Invitrogen.com). 
This allows in vivo live cell analysis of localization and trafficking of the protein.  
The LumioTM Green Labeling Reagent is based on the FlAsH reagent and is a 
non-fluorescent, biarsenical derivative of fluorescein. The reagent can fluoresce 
when bound to the tetracysteine tag and excited at 508 nm with an emission 
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maxima at 608 nm (Invitrogen.com).  This reagent can be used for live cell 
imaging and has been used for flourescnece recovery after photobleaching 
(FRAP) analyses in our experiments. The Lumio Red Labeling Reagent is based 
on the ReAsH reagent and is a non-fluorescent, biarsenical derivative of the red 
fluorophore resorufin (Invitrogen.com). This reagent can fluoresce when bound to 
the tetra-cysteine tag and excited at 593 nm laser. It has emission maxima of 608 
nm (Invitrogen.com). This reagent has the ability to release free radicals in the 
presence of bright light and photoconvert diaminobenzidine to an electron dense 
photoprecipitate (Gaietta et al. 2006) 
. While the technology for photoconversion has been around for a while, 
this is the first system that used a small tag to fluorescently label a protein and use 
the same tag to combine light and electron microscopy. The project involved 
extensive use of the SOLS bioimaging facilities, including the Keck Bioimaging 
Lab confocal and EM microscopes. Establishment of this state-of-the-art imaging 
capability helped provide significant new information on the role of the E protein 
in coronavirus assembly. This powerful technology can be easily adapted for use 
in various projects. I have provided a generalized description of the methodology 
used to establish this technology during my graduate work. 
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Figure 21: Protocol for Correlative Live Imaging and Electron Microscopy 
Cells were grown in a glass bottomed gridded coverslip. Flourescent images were 
obtained of specific cells and the position of the cell on a grid was noted. 
Confocal images of specific cells were obtained. Flourescent signals were 
converted to electron dense precipitate. The coverslip was processed for electron 
microscopy and embedded in resin. Based on the grid position of the cell of 
interest, the cell was excised using a razor blade and ultra thin (70m) serial 
sections of the specific cells were obtained and electron micrographs were 
obtained.  
Adapted with permission from Nature Methods 5, 973 - 980 (2008)     
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MATERIALS 
1. 35mm Glass bottomed cell culture dish with gridded coverslip of No. 1 
thickness (MatTek) 
2. Dry lubricant spray (Electron Microscopy Sciences) 
3. Glutaraldehyde (Sigma  Aldrich) 
4. Phosphate buffer pH 7.4 
5. DTT (Sigma Aldrich) 
6. Sodium Cacodylate buffer 
7. Blocking buffer: 10 mM KCN, 10 mM aminotriazole, 0.01% hydrogen 
peroxide, 50 mM glycine in 0.1 M cacodylate buffer 
8. Diaminobenzidine at 1mg/ml in blocking buffer 
9. Cells 
10. Tetracysteine tagged protein 
11. Lumio Green or Lumio Red In Cell staining kit (Invitrogen) 
12. Kim-Wipes 
13. dH2 0 
14. 2% Osmium tetroxide (Electron Microscopy Sciences) 
15. Eponate 12 resin (Electron Microscopy Sciences) 
16. Laminar flow hood 
17. Cell culture incubator (37 0C and 5% CO2) 
18. Confocal microscope with heated stage, humidifier and heated objective 
lens 
19. Ultra Microtome  
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20. Transmission Electron microscope (Philips 80kV STEM) 
METHODS 
Initial preparation 
1. Spray glass-bottomed coverslip with dry lubricant, allow to dry and wipe 
down twice with Kim wipe. 
2. Place dish open in the laminar flow hood and expose to UV for atleast 90 
minutes. 
3. Seed susceptible cells at required density. 
4. Infect or transfect cells with appropriately tagged virus or protein. 
5. At specific time post infection or transfection, label the cells with the 
Lumio Green or Lumio Red reagent 
Lumio Staining 
1. Aspirate media and wash cells twice with any reduced serum media such as 
Opti-MEM. 
2. Add Lumio Green or Lumio Red at a final concentration of 1mM to the 
cells. 
3. Place immediately back in the in the incubator for 30 min to 1 hour 
depending on the level of expression of the tagged protein. 
4. Aspirate media and wash cells twice with reduced serum media. 
5. Add DTT at a final concentration of 1mM to the cells. 
6. Place immediately back in the incubator for 10 min. 
7. Repeat steps 5 and 6 atleast twice. 
8. Refeed cells with complete media and allow cells to recover for 1 hour. 
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   For Live Cell imaging and FRAP 
1. Prepare the confocal microscope stage with the live cell imaging chamber. 
2. Ensure that the chamber temperature, humidity and CO2 levels are 
equilibrated for optimal cell survival. 
3. Collect images using appropriate lasers (489 nm for Lumio Green and 545 
nm for Lumio Red). 
4. Adjust laser power, pin-hole opening, detection gain to ensure best signal- 
to –noise ratio. 
5. For live cell imaging, ensure that the temperature, humidity and CO2  levels 
are maintained constant throughout the experiment. 
6. For FRAP analysis, measure a pre-bleach image using low laser power and 
a completely open pin-hole. 
7. Choose a specific region for photo bleaching such that the bleached volume 
is an insignificant portion of the total signal volume using the high laser 
power to ensure complete photo bleaching. 
8. This is important for Lumio stained samples because unlike GFP tagged 
proteins, the total amount of stained protein remains the same throughout 
the experiment. 
9. Immediately upon bleaching collect images using pre-bleach settings with 
very short intervals such as 1- 5 seconds.  
10. Analyze the mobility fraction as the ratio of the recovered intensity over the 
bleached density. 
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For Correlative Live and Electron Microscopy (CLEM) 
1. Only Lumio Red or ReAsH is capable of photoconversion and must be 
used for CLEM. 
2. Capture live cell images as described above. 
3. Obtain the location of the cell in the gridded coverslip using phase contrast 
or DIC imaging. 
4. Keep careful record of fluorescent images and their position on the gridded 
coverslip. 
5. Once all fluorescent images are obtained, photoconversion is carried out. 
6. Aspirate media and wash cells twice in Phosphate buffer pH 7.4. 
7. Fix cells in 2% glutaraldehyde sodium cacodylate buffer at room 
temperature for 1 hour. Ensure that the cells are not disturbed during the 
process of fixation. 
8. Aspirate the fixative and wash cells in blocking buffer. 
9. Incubate at room temperature for 10 minutes. 
10. Replace blocking buffer with freshly prepared 1mg/ml diaminobenzidine in 
blocking buffer. 
11. Carry our photoconversion using a 75W Xenon lamp without neutral 
density filters focused through the 10X objective. 
12. Capture the photoconverted images of previously images cells using the 
position of the cells recorded from the gridded coverslip. 
Processing for electron microscopy 
1. Aspirate the photoconversion buffer from the cells. 
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2. Wash cells twice in water. 
3. Add 0.1 M Osmium tetroxide to the dish and incubate at room temperature 
for 1 hour 
4. Wash cells twice in water. 
5. Dehydrate cells in increasing concentration of acetone for 10 minutes each. 
6. Complete hydration with 100 % acetone three times for 10 minutes each. 
7. Resin infiltration: 
a. Make up fresh Eponate 12 resin (medium hard) 
b. Make increasing concentrations of Eponate- 12 in acetone (25, 50, 
70 %) and treat the cells for 8 hours each. At this time, the cells are 
placed on a rocker to allow even resin distribution. 
c. Treat the cells with 100 % resin 3X for 12 hours each. 
8. Place dish in 65 0 C incubator for 48 hours. 
9. Once polymerization is complete, freeze the dish -20 0 C for 10 minutes. 
10. Detach the resin from the dish. 
11. An image of the gridded coverslip will be transferred with the detached 
resin, along with the cells. 
12. Cut out individual cells observed using the location of the cell on the 
gridded coverslip. 
13. Place the individual cells on resin blocks using Superglue and allow to set 
overnight. 
14. Trim and section the cells using an ultramicrotome at 60-70 nm thickness. 
15. Collect serial sections and observe samples in the electron microscope.
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